Welcome to article directory Knight News Commission. Here You can find interesting and useful information on most popular themes.
There are 517 published articles and 1897 registered authors in our article directory.
- Actos Attorney (1)
- No categories
- Actos Lawsuit (3)
- No categories
- Byetta Attorney (1)
- No categories
- Byetta Lawsuit (2)
- No categories
- Emerging Mass Torts (262)
- No categories
-
- No categories
- Fosamax Lawsuit (1)
- No categories
-
- No categories
- Januvia Lawyer (1)
- No categories
- Mass Torts (1)
- No categories
-
- No categories
-
- No categories
- Paxil Lawyer (1)
- No categories
-
- No categories
-
- No categories
-
- No categories
-
- No categories
- Tekturna Lawyer (1)
- No categories
- Yaz Blood Clots (1)
- No categories
- Yaz Lawsuit (5)
- No categories
- Yaz Lawyers (1)
- No categories
- Zoloft Lawsuit (1)
- No categories
-
- No categories
- Actos Litigation (1)
- No categories
- Byetta Attorneys (2)
- No categories
- Byetta Lawyer (1)
- No categories
-
- No categories
-
- No categories
- Hip Recall (1)
- No categories
-
- No categories
-
- No categories
- Mesothelioma (1)
- No categories
-
- No categories
- Neural Tube Defect (10)
- No categories
- Pradaxa Lawsuit (1)
- No categories
-
- No categories
-
- No categories
- Spina Bifida (27)
- No categories
-
- No categories
- Tekturna Lawyers (0)
- No categories
- Yaz Class Action (1)
- No categories
- Yaz Lawsuits (1)
- No categories
- Yaz Recall (0)
- No categories
-
- No categories
-
- No categories
-
- No categories
-
- No categories
-
- No categories
-
- No categories
- Januvia Attorney (1)
- No categories
- Januvia Lawsuit (1)
- No categories
- Mass Tort (1)
- No categories
-
- No categories
-
- No categories
- Paxil Lawsuit (3)
- No categories
- Pradxa Lawsuit (1)
- No categories
-
- No categories
- Small Cell (0)
- No categories
-
- No categories
- Tekturna Lawsuit (1)
- No categories
- Uncategorized (77)
- No categories
-
- No categories
- Yaz Lawyer (1)
- No categories
- Yaz Recall (1)
- No categories
Recent Articles
Actos Lawsuit Discovery
acActos Lawsuit: There is a very close relationship between survival of an individual and the stage of bladder cancer at diagnosis. For superficial disease, five year survival rates are greater than 90%. Once the cancer has spread into the bladder muscle and beyond, survival is markedly reduced. Five year survival in those with T2 disease (tumor invading superficial bladder muscle) is 60-75%, T3 disease (tumor invading deep muscle) 36-58%, and for those with T4 disease (tumor invading surrounding organs) or with node positive disease, 4-35%.’ With distant (metastatic) spread, survival at five years is less than 5%.
Most individuals with bladder cancer will undergo an initial removal of their bladder tumor by biopsy or for larger tumors by resection of their tumor via a resectoscope. For complete details see Chapter 8. Once this tumor is removed, the pathologist will determine and report on the extent of tumor invasion into the wall of the bladder. If the tumor has grown into the prostate, tissue removal via the resectoscope from this location will also be reviewed and reported pathologically. This pathologic diagnosis determines the initial stage of the cancer.
When dealing with large tumors after the initial cancer resection, your urologist may do a manual exam under anesthesia. By pressing deeply on the pelvis, the urologist may be able to palpate the tumor and assess its possible spread beyond the bladder. With modern technology and the availability of the CT scan, the manual exam is now of less importance. The CT scan can often visualize a thickened or distorted bladder wall, indicating the possibility of tumor involvement or extension through the wall. More importantly, it can determine spread to adjacent organs or lymph node involvement. Distant spread into the abdomen or beyond may also be seen. Other studies, such as the Bone Scan or Chest X ray can assess the presence and extent of metastatic diseases, MRI can be used for those with limited kidney function that cannot have a CT scan. More recently, Positron Emission Tomography (PET) scan has become available. This study can sometimes locate small deposits of metastatic disease not visible on CT or MRI scan.
Our use of the term or terms Actos Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
Actos Lawsuit
Paxil Lawsuit Process Notice
Paxil Lawsuit News – 5/14/2012: Did you take Paxil? Please contact us today if you took Paxil and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.
Paxil Lawsuit: Of the more than 600 lawsuits against Glaxo, this case was the first Paxil birth defect lawsuit to go to trial. According to the complaint, the child’s mother took Paxil as prescribed by her doctor during her pregnancy. The child suffered from a direct Paxil side effect. The manufacturer disagrees with the verdict and stated that they would appeal. There seem to be serious potential risks to taking Paxil while pregnant. There are many lawsuits against Paxil because of the negative side effects that are possible. If you or someone you know has a baby who was born with a birth defect because of using Paxil during pregnancy, you should contact a Paxil birth defects attorney. No child should have to suffer from a heart defect as a result of a medication taken during pregnancy. You should consult your physician and speak in detail regarding Paxil’s potential risks. You should also consider switching to a different antidepressant if these medications are absolutely necessary for you to take.
Paxil Lawsuit News: News and Information
Paxil Lawsuit: Risks of taking this drug may need to be updated and made even stronger in order to fully provide information to people who are considering taking the medication. Paxil is considered to be an antidepressant, specifically a selective serotonin reuptake inhibitors (SSRI). The drug works by restoring the balance of serotonin in the brain. Serotonin helps to improve certain mood problems. Paxil has been used to treat depression, obsessive-compulsive disorder, anxiety disorders, post-traumatic stress disorder and premenstrual dysphoric disorder. Like any other drug, there are side effects from Paxil that need to be made apparent to those who are taking the drug. Because of the side effects, there have been Paxil lawsuits.
Our use of the term or terms Paxil Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Paxil Lawsuit visit our site often.
Paxil Lawsuit Process
Actos Lawsuit Enlightenment
Actos Lawsuit: A small amount of microscopic hematuria in an individual without symptoms (asymptomatic microscopic hematuria) can be found in many healthy individuals. It has been estimated that up to 10% of the population has asymptomatic microscopic hematuria. In brief, the older you are (generally over the age of 40), the more risk factors you have (smoking, occupational exposure), and the more red blood cells present, the more likely serious pathology (disease of the urinary tract including bladder cancer) will be found. If you have persistent microscopic hematuria without a known cause, a urologic assessment is recommended.
When assessment for hematuria is required, the entire urinary tract is evaluated. This is accomplished via imaging studies (X ray or ultrasound), cystoscopy (visual inspection of the bladder), and possibly cytology (urine test for cancer cells). There are multiple causes for blood in the urine, including the possibility of kidney disease, kidney, ureteral or bladder stones, infection, or enlargement of the prostate. Approximately twenty percent of patients with bladder cancer will complain of irritative voiding symptoms. These symptoms include urinary urgency (a need to rush to the bathroom), burning and urinary frequency. These same symptoms are present in other urologic conditions such as infection, bladder instability and prostatic enlargement in men. These symptoms are most commonly associated with a diffuse superficial form of transitional cell cancer of the bladder called CIS (carcinoma in situ). Unfortunately for some, their diagnosis may be delayed since these symptoms are present in so many other diseases.
Actos Lawsuit
Paxil Lawsuit Reports
Paxil Lawsuit News – 5/11/2012: Did you take Paxil? Please contact us today if you took Paxil and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.
Paxil Lawsuit: Studies have suggested a link between the use of Paxil during pregnancy and birth defects. Paxil is an antidepressant that is classified as a Selective Serotonin Reuptake Inhibitor (SSRI). Among all the studies, it was concluded that women who took Paxil while pregnant increased the risk of their children developing birth defects, particularly heart defects. The side effects of Paxilare dangerous and can be potentially life-threatening so it is important to be aware of all the risks. Before the studies were conducted, the U.S. Food and Drug Administration (FDA) issued a Paxil warning to doctors, other healthcare professionals and patients. The FDA Paxil warning alerted the public about the increased risk of congenital malformations, particularly heart malformations, as a result of using Paxil during the first trimester of pregnancy. In 2006, after the FDA warning for Paxil users, the American College of Obstetricians and Gynecologists (ACOG) warned pregnant women to avoid taking the prescription medication Paxil. ACOG officials specifically noted the detrimental side effects of Paxilregarding heart defects for newborns.
Some of the latest studies, performed in association with the CDC, make note of the Paxil side effects and suggest an increased risk of neonatal heart defects for the infants of obese women who were pregnant and used Paxil. Another study that was published in The New England Journal of Medicine also suggested that heart defects were a side effect of Paxil. These Paxil birth defects obstruct the blood flow from the heart to the lungs. Heart defects are not the only side effects associated with Paxil. Another Paxil birth defect includes a lung condition called Persistent Pulmonary Hypertension (PPHN). Babies born with PPHN have difficulty getting enough oxygen to their lungs and may possibly suffer from heart failure. The side effects of Paxil are potentially dangerous and life-threatening and should be considered by mothers who are pregnant before beginning the use of the antidepressant Paxil. If your baby was born with a medical condition as a result of being exposed to Paxil, you should contact a Paxil birth defects lawyer for a consultation.
Our use of the term or terms Paxil Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Paxil Lawsuit visit our site often.
Paxil Lawsuit
Actos Lawsuit Headlines
Actos Lawsuit: T2 lesions: tumors in this stage have superficially invaded the muscularis propria, the thick muscle layer of the bladder. These tumors usually are high grade. Although they may be amenable to local therapy, they have a high rate of further invasion and are at high risk for developing metastatic disease. T3 lesions: these tumors are almost always high grade, nodular, and very aggressive. Unfortunately, many may actually be understaged tumors with the cancer already spread beyond the confines of the bladder. When an individual develops muscle invasive bladder cancer, major intervention is required to prevent spread and save the life of the individual. T4 lesions: high grade invasive, aggressive tumors which have invaded adjacent organs. Many of these have also spread to distant parts of the body (are understaged) and are incurable.
A number of other factors may be utilized to help predict the likelihood of recurrence and progression of an individual’s bladder cancer after treatment. Tumor size: There generally is little difference in the recurrence rates of small tumors (tumors approximately 1-3 cm in size or V2-I Vi inches in size). As tumors grow to mid size and larger, it is generally believed that recurrence rates are increased. Tumor Configuration: More important than the size alone is the actual appearance of the tumor. Tumors that are papillary in appearance usually have a better prognosis than tumors that are solid (sessile or nodular). Multifocality: When multiple tumors are present, scattered over various sites, the prognosis is worsened. If CIS is present in conjunction with bladder tumors, the rate of recurrence and progression is markedly worsened. Having multiple sites affected represents a widespread abnormal urothelium with an increased risk of future disease.
Our use of the term or terms Actos Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
Actos Lawsuit
Paxil Lawsuit Advice
Paxil Lawsuit News – 5/9/2012: Please contact us today if you took Paxil and suffered unusual side effects or other injuries.
Paxil Lawsuit: Used for the treatment of depression and anxiety, Paxil® is a type of drug known as selective serotonin reuptake inhibitor (SSRI). Alerts were previously issued by the U.S. Food and Drug Administration to inform the public of potential increased risks to fetal development if Paxil® is prescribed during the first trimester of pregnancy. A Paxil Birth Defect Attorney has the knowledge to represent individuals who believe they have been injured because of taking Paxil®. Women who took Paxil® during their pregnancy and gave birth to a baby with birth defects should act quickly to determine if they are eligible to file a claim. Complete the form above or call Best Legal Source at 800-611-7080 and we’ll get you in touch with a Paxil Birth Defect Attorney.
Individuals who have taken Paxil were possibly subjected to serious risks and not adequately informed when first prescribed Paxil®. These risks can include severe birth injuries, such as heart defects and Persistent Pulmonary Hypertension of the Newborn. Women taking Paxil® who are pregnant or plan on becoming pregnant should discuss the potential risks with their healthcare provider. A qualified and experienced Paxil Birth Defect Attorney is waiting to assist you with your case.
The owners of this website are not the makers of Paxil® and do not have any affiliation, connection, or relationship with the makers of Paxil®. If you are looking for information directly from the makers of Paxil®, this is not their website. Paxil Birth Defect Attorney is a general term used to describe the legal process and services provided by an attorney experienced with Paxil lawsuits and similar cases. The use of the term Paxil Birth Defect Attorney or any other phrase containing the word Paxil® does not imply any connection or relationship between the makers of Paxil® and the owners of this website. Best Legal Source does not represent the manufacturer, but rather is here to offer help in locating a Paxil Birth Defect Attorney if you or a loved one has suffered from use of this drug.
 
Women who believe they have suffered because of taking the drug Paxil® could be eligible for compensation for hospital and medical costs, pain and suffering, and lost wages. Fill out the form to the right or call 800-611-7080 and Best Legal Source will connect you with a Paxil Birth Defect Attorney who can lead you through the legal process.
Our use of the term or terms Paxil Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Paxil Lawsuit visit our site often.
Paxil Lawsuit
Actos Lawsuit Important Info
Actos Lawsuit: Experience also counts. As a physician practices the art of medicine, his depth of knowledge and ability to treat grows. Ask your physician how long he has been treating patients with bladder cancer. If you require major surgery ask how many he has performed and if his complication rate matches what is expected. Physicians by and large do improve as they practice, and all physicians are required to show that they are continuing to learn by partaking in continuing medical education, a requirement to remain licensed. Most physicians are compulsive in their medical practice and care deeply in the care they deliver. They continually strive to improve. Some physicians may become “burned out” over the years as they continue to face the pressures of a busy medical practice. Similarly, towards the end of a surgeon’s career, technical skills may slip due to aging. New urologists are trained in the latest techniques and are familiar with recent medical literature, but may lack practical experience. In the end, recommendations from others and reputation may be your best guide to finding a qualified physician.
Our use of the term or terms Actos Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
Actos Lawsuit
Paxil Lawsuit Breaking News
Paxil Lawsuit News – 5/11/2012: Did you take Paxil? Please contact us today if you took Paxil and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.
Paxil Lawsuit: Studies have suggested that there is an increased risk of Paxil birth defects for women who took Paxil during the first trimester of their pregnancy. A Paxil birth defect would include having a baby with a heart malformation. Studies have also suggested that women taking Paxil during their first trimester were more likely to have a child with a heart malformation when compared to any other SSRI. Another study also suggested an additional risk for taking Paxil during pregnancy by proposing a link between Paxil and persistent pulmonary hypertension (PPHN). PPHN is a rare but life-threatening birth defect that can potentially lead to multiple organ failure and death. In 2005, an FDA warning for Paxil users alerted consumers to the increased risks of Paxil bad side effects when mothers take Paxil during the first three months of pregnancy. These adverse effects of Paxil include heart defects such as atrial and ventricular septal defects. These defects are characterized by holes in the walls of the chambers of the heart. The heart-related defects that may be associated with Paxil range in severity from minor to severe conditions. In some cases, minor heart defects may be resolved without treatment while severe conditions usually require surgery. A Paxil baby may suffer from other side effects as well. These other possible birth defects and complications include difficulties with breathing, seizures, vomiting, low blood sugar, tremors and irritability. As a result of the risks of Paxil birth defects, the FDA asked the manufacturers to change the pregnancy category from C to D, indicating that studies done in pregnant women have shown risks to the fetus. If your baby, or the baby of someone you know, was born with a birth defect while you were taking Paxil, contact a Paxil lawyer for advice on how to pursue a Paxil birth defect lawsuit.
Paxil and side effects. Paxil, a selective serotonin reuptake inhibitor (SSRI), is a prescription medication that is known as an antidepressant. Paxil is used as treatment for a number of different conditions. Some of those conditions include depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder and post-traumatic stress disorder. It is manufactured by GlaxoSmithKline, a large pharmaceutical company. While the intent of this drug is positive and can provide benefits, there are also serious side effects of Paxil. Not everyone experiences these Paxil side effects, just like everyone doesn’t experience the side effects of other drugs; however, it is important to know the risks before taking Paxil.
Our use of the term or terms Paxil Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Paxil Lawsuit visit our site often.
Paxil Lawsuit
Actos Lawsuit Important Information
Actos Lawsuit: You may need to be referred to an oncologist, a physician specialist in the medical therapy of cancer. At times, a referral to a radiation oncologist, a specialist who treats cancer with radiation, may be required. Other individuals may need to be consulted as well. It is important for your urologist to keep your primary care physician up to date so that he can coordinate your care and if required by your insurance plan, make the appropriate referrals. On a regular basis, magazine articles, books, and television shows implore those with major illnesses to seek out a second opinion. The general consensus is there is much to be gained and little to be lost, so why not seek out a second opinion? The issue certainly is more complicated than generally addressed, and deserves a review.
In general, a competent physician will recommend a second opinion if there is uncertainty regarding your care. This uncertainty could involve the pathology report or debate regarding the most appropriate treatment options. Certainly if the pathology report is in question, a second opinion is mandatory! Your urologist should be able to spell out his treatment plans for you, what to expect and what alternatives may be required, depending on the seriousness of your disease. The plan may change over time as your disease improves or worsens.
You may need a second opinion if you are not doing well and your physician is unable to provide satisfactory explanations and solutions. Occasionally, your urologist may recommend a second opinion if your problem is unusual or particularly complicated. Having a physician you can trust is mandatory when dealing with cancer. Don’t let anyone pressure you into a second opinion if you feel confident in your physician’s abilities. On the other hand, if you are uncomfortable with your progress or a treatment recommendation, if you are not satisfied with the explanations given to you, don’t hesitate to seek out a second opinion. Your urologist should not feel threatened by this request as he wants you to feel comfortable with the plan of action. Only by partnering with your physician can he be most effective.
Actos Lawsuit
Paxil Lawsuit News
Paxil Lawsuit News – 5/9/2012: Did you take Paxil? Please contact us today if you took Paxil and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.
Paxil Lawsuit: In light of recent research that examined the association between Paxil® and birth defects, many authorities believe the possible risk of adverse effects to the fetus caused by taking Paxil® is too significant for the drug to be taken by pregnant women. Therefore, if you or someone you know took Paxil® and gave birth to a baby with birth defects, fill out the form to the right or call 800-611-7080 and you will be put in touch with Paxil Birth Defect Lawyers for assistance with your legal rights.
Studies have shown that infants exposed to Paxil® during the first three months of pregnancy have an increased risk of congenital malformations, especially cardiovascular abnormalities. The most common types of heart defects noted were atrial septal defects and ventricular septal defects (holes in the walls between the chambers of the heart). Patients should notify their healthcare providers if they are pregnant or intend to become pregnant while on Paxil®. Whenever a baby is born with birth defects, it brings about permanent and difficult changes in the family’s life. If your baby suffers from heart defects and you were taking Paxil® during pregnancy, you may wish to contact Paxil Birth Defect Lawyers.
Best Legal Source is not associated in any way with the makers of Paxil®. Please go to the Paxil manufacturer’s website if you are seeking information from the company that makes Paxil®. Paxil Birth Defect Lawyers is a general term used to describe the legal process provided by an attorney experienced in Paxil lawsuits and similar cases. The use of the term Paxil Birth Defect Lawyers as well as other phrases containing the word Paxil® does not imply any connection or relationship between the makers of Paxil® and the owners of this website.
If you have taken the drug Paxil® and believe that you have suffered from its side effects, Best Legal Source can put you in touch with a team of Paxil Birth Defect Lawyers. Complete the form to the right or call 800-611-7080 to contact a knowledgeable attorney. You will need adequate representation and may be eligible for monetary compensation.
Our use of the term or terms Paxil Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Paxil Lawsuit visit our site often.
Paxil Lawsuit
Judge Grants Extension In Yaz Lawsuit
The judge assigned to handle the Yaz Lawsuit, Multi District Litigation, often referred to as the Yaz Class Action Lawsuit, has granted more time to Bayer, the maker of Yaz and the plaintiff law firms representing over 11,000 claimants, to settle the case before a trail begins.
To date 651 cases have been settled for a total of $142,000,000. This represents an average per Yaz Lawsuit case settlement of approximately $218,000 dollars. Current estimates that Bayer will have to spend in excess of two and a half billion dollars to settle the remainder of the current pending Yaz Lawsuit cases.
Although the United States Food and Drug Administration did not officially announce the problems associated with Yaz until 2011, numerous lawsuits had already been filed. The issue with Yaz that has led to the massive number of lawsuits being filed stems from one of the ingredients in Yaz, drospirenone. Drospiredone has been linked to an increased incident of blood clots occurring in women who take birth control pills containing this ingredient. The primary ingredients in Yaz are a generic form of estrogen that has been used in birth control pills for many years and the additional ingredient Drospiredone.
As early as 2011 there were reports of women and teenage girls dying from blood clot related medical problems that have now officially been linked to Yaz. When the problems were first reported the manufacturer denied any responsibility for the deaths and other medical issues related to Yaz however, the drug company is working diligently with those who have filed Yaz Lawsuits to settle the cases without the need for a trail, although they still refuse to admit any liability or wrong doing.
New Yaz Lawsuits are still being filed. Given that there was no official recognition of the relationship between Yaz and blood clot related medical problems until 2011, the time limit to file Yaz Lawsuits has not expired. Women who took Yaz and suffered blood clot related problems such as strokes, deep vein thrombosis, pulmonary embolisms.
For more information on Yaz Lawsuits or to arrange a consultation with a Yaz Lawyer contact Best Legal Source at (800) 611-7080
Paxil Lawsuit Broadcast
Paxil Lawsuit News – 5/11/2012: Please contact us today if you took drug name and suffered unusual side effects or other injuries.
Paxil Lawsuit: Paxil birth defects have occurred after taking this antidepressant drug during pregnancy. Paxil is a selective serotonin reuptake inhibitor (SSRI). Mothers that take Paxil during pregnancy put their unborn babies at an increased risk for developing Paxil birth defects. Since there are increasing numbers of birth defects from Paxil, there are many families and other individuals that have filed a Paxil birth defects lawsuit. The SSRI drug Paxil is prescribed to treat depression. It has increasingly been reported that Paxil has been linked to serious birth defects in unborn babies of women that take Paxil while pregnant. The specific degree of risk for developing the side effects of Paxil is currently unknown; however, the risks of babies being born with serious side effects from Paxil following the use of this drug have been reported. Physicians and other healthcare professionals state it is inadvisable for women to use Paxil during their pregnancy because this is when they can expose their baby to the potentially harmful antidepressant.
Some harmful Paxil side effects include persistent pulmonary hypertension (PPHN), abdominal birth defects, heart birth defects and cranial birth defects. In 2006, the Food and Drug Administration (FDA) issued a Paxil warning about the increased risk of developing PPHN, a considerably dangerous side effect of Paxil. PPHN is a serious and life threatening condition that takes place in the lungs and occurs soon after birth. Labels on the Paxil bottles were also revised to include additional information concerning a study that suggested exposure to Paxil during the first trimester of pregnancy may be associated with an increased risk of babies being born with cardiac problems. If your child or the child of someone you know has suffered from the adverse effects of Paxil, please contact a Paxil birth defects lawyer in order to receive a consultation regarding your claim. A Paxil lawyer will be able to assist you in the next steps you take to receive any compensation to which you may be entitled because of the direct effects that Paxil has had on you, your child and the rest of your family.
Our use of the term or terms Paxil Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Paxil Lawsuit visit our site often.
Paxil Lawsuit
Paxil Lawsuit News – 5/9/2012: If you were prescribed Paxil and have suffered negative side effects, please contact us today so that we can put you in touch with an attorney to advise you of your legal rights.
Paxil Lawsuit: A Paxil Lawsuit is a prospective option for you if your child was born with a birth injury after you took Paxil during your pregnancy. Currently, the U.S. Food and Drug Administration lists an active safety alert for Paxil. This safety message may positively impact the legitimacy of your possible Paxil Lawsuit. In December of 2011, the FDA updated the public about selective serotonin reuptake inhibitor antidepressants (SSRIs) and their potential risk of rare heart and lung conditions in newborn children. Best Legal Source works in the legal business to help injured parties find seasoned Paxil Lawsuit attorneys for their possible Paxil Lawsuit. If you are interested in learning more about our complimentary service, call Best Legal Source at (800) 611-7080 or message us through the form to your right. We can give you prompt assistance regarding a Paxil Lawsuit for your child’s birth defect.
A Paxil Lawsuit is filed often because of birth defects or serotonin syndrome. This page is designed to assist those looking for a Paxil Lawsuit in regards to their newborn child’s birth defect. The rare heart and lung condition associated with Paxil is called persistent pulmonary hypertension of the newborn (PPHN). You know the lifelong challenges a birth injury can cause for an individual. In addition to emotional pain, a birth defect can create financial strain for the family. A Paxil Lawsuit could result in a settlement that erases the financial burdens of costly medical bills. Imagine having the ability to pay for the surgeries your child desperately needs to have a chance at a more normal life. This dream can become a reality through the possible Paxil Lawsuit.
Paxil Lawsuit and Paxil Lawsuit attorney are phrases used to describe the specific drug involved and the possible legal action that may be taken against Paxil. The possibility of a Paxil Lawsuit means attorneys may be looking into this case on a contingency basis with no outside fees or cost to you, the injured party. Best Legal Source is not connected to the manufacturer of the drug Paxil. Our goal is to help those who have been harmed by Paxil side effects to understand the process of filing litigation through a Paxil Lawsuit.
A Paxil Lawsuit can be pursued on your behalf. Call Best Legal Source at 800-611-7080 to be put in contact with an informed, qualified Paxil Lawsuit attorney. The side effects of Paxil have the potential to be dangerous and can even take away from your newborn child’s quality of life. You have a limited period of time to pursue action against Paxil by filing a Paxil Lawsuit. Best Legal Source will make this journey easier for you, but time is vital. Call us now to have the best chance of a successful Paxil Lawsuit.
Please contact Best Legal Source today by using the form to the right or calling 800-611-7080. Best Legal Source will assist you in taking action against the Paxil side effects you’ve endured by utilizing the assistance of an experienced Paxil Lawsuit attorney. Let Best Legal Source find the best possible Paxil Lawsuit prosecutor for you.
Our use of the term or terms Paxil Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Paxil Lawsuit visit our site often.
Yaz Lawsuit Process
Yaz Lawsuit News – 5/9/2012: If you were prescribed Yaz and have suffered negative side effects, please contact us today so that we can put you in touch with an attorney to advise you of your legal rights.
Yaz Lawsuit: If you are considering a Yaz Class Action because you experienced blood clots or a stroke while taking this contraceptive, you should speak with an experienced Yaz Lawyer to discuss your legal rights. The risks of blood clots increase with the use of oral contraceptives such as Yaz and can lead to heart attacks, stroke, pulmonary embolism and deep vein thrombosis. If you or a loved one has suffered from any potential side effect of taking Yaz and are experiencing mounting medical bills, you may be entitled to financial compensation through a Yaz Class Action Lawsuit. Yaz Lawyers can help you through this complicated process.
A Yaz Class Action is a general term used to describe the legal process and service provided by Yaz Lawyers who pursue a joint case for a group of victims. Using the terms Yaz Class Action, Yaz Class Action Lawsuit, Yaz Lawyer and Yaz Lawyers does not imply any connection between the makers of Yaz and Best Legal Source. Best Legal Source helps women who developed similar injuries find Yaz Lawyers capable of pursuing a Yaz Class Action Lawsuit for them.
Our use of the term or terms Yaz Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Yaz Lawsuit visit our site often.
Yaz Lawsuit Action
Yaz Lawsuit News 5/7/2012: If you were prescribed Yaz and have suffered negative side effects, please contact us today so that we can put you in touch with an attorney to advise you of your legal rights.
Yaz Lawsuit: Pharmaceutical companies that manufacture contraceptives might be faced with claims, such as Yaz Lawsuits, regarding safety issues. Specifically, the most recent cases involve Yaz Blood Clots. For women who are currently on birth control, it is vital to be aware of the risks involved with using these medications. Yaz has a growing number of individuals pursuing Yaz Lawsuit claims against their company. The severity of your Yaz Blood Clots may lead you to begin looking for a Yaz Lawsuit attorney. Best Legal Source will connect you with a Yaz Lawsuit lawyer capable to give you the knowledge needed to file a Yaz Blood Clots case.
Your doctor will perform the first examination for incontinence or prolapse in the same way as all gynecologic exams are done. The doctor will have you lie on your back on the examining table with your feet in stirrups. The uterus, fallopian tubes, and ovaries will be examined to make sure they feel normal. Even if you have had a hysterectomy, the doctor will perform an internal exam to make sure nothing else is pushing down on the vagina or rectum. The vagina will then be examined a bit more carefully to see if the bladder or rectum is pushing against a weakened vaginal wall, causing a visible bulge. You will be asked to cough or bear down so that any weakness in the muscles supporting the bladder or rectum is made more apparent. The extra pressure will make weakened areas bulge further. Childbirth, gravity, menopause, aging, and heredity may all contribute to the problem of sagging or dropping of these organs.
Yaz Lawsuit News: More information about your search
Yaz Lawsuit: The areas around the vagina and rectum will be touched with a Q-tip, and the doctor will record your ability to feel that touch. If you are unable to feel the Q-tip touching you, there may be a problem with die nerves in the area of the bladder or rectum. In that case, you may be referred to a neurologist for further evaluation. Some neurological conditions, such as back injuries, strokes, diabetes, and multiple sclerosis, can affect the muscles that aid bladder function.
After the pelvic examination, other tests may be employed to help determine which type of incontinence you have. We routinely perform two simple tests called the cough stress test and the Q-tip test. The cough stress test is performed with you lying on the exam table with your feet in stirrups. You are asked to cough with a full bladder to see if that causes leakage of urine. The Q-tip test is performed in the same position. A cotton-tipped swab covered with anesthetic gel is painlessly inserted into the urethra, the bladder opening. You are asked to cough and strain, and the doctor or nurse measures the movement of the end of the Q-tip (Figure 3-1). Excessive movement of the Q-tip or loss of urine with coughing usually indicates a weakening of the tissues supporting the urethra that is associated with stress incontinence.
Keyword News: Additional Information and Resources
During the first office visit, your doctor will probably ask you how often you urinate, how much liquid you drink in a day, and how often you have accidents. The answers to these questions are a good start, but a written record of these events may more specifically illustrate what happens with your bladder during the course of your day. This written record is called a voiding diary, or urolog. It is intended to be a one- or two-day record of how much liquid you drink, the amount and frequency of your urination, and how much leaking you have. Because a written record is better than relying on your memory, the voiding diary is a very accurate method of determining just how significant the incontinence problem is. All of the patients in our practice fill out a voiding diary.
Our use of the term or terms Yaz Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Yaz Lawsuit visit our site often.
Death of Canadian Teacher may have been caused by Asbestos
It’s commonly known that the inhalation of loose asbestos fibers can increase the risk of a number of deadly lung illnesses, including mesothelioma. Sadly, the recent death of a teacher at the University of Calgary is yet another example of this.
Mesothelioma Causes: According to the CBC, Ameila Labbe ran the Spanish center inside Craigie Hall at the university during renovations to the building in 2003 as well as an asbestos management project that was undertaken in 2006. During the renovations, many teachers in the building complained of poor air quality due to dust that drifted from the work sites.
“Ceiling tiles and accumulated dust from the ceiling space had spilled into the work area and had basically resulted in air quality in which those of us who were within the entire wing could not breathe,” said Rachel Schmidt, the head of the French, Italian, and Spanish departments at the time.
She added that the department eventually shut down until debris was cleaned up. Unfortunately for Labbe, she was eventually diagnosed with pulmonary fibrosis and succumbed to the lung disease last November. Her husband told the CBC that he believes the loose dust from the 2003 renovation that may have contained asbestos led to the illness that killed her.
Mesothelioma Attorneys: If you or a loved one has been exposed to loose asbestos fibers and now suffer from mesothelioma, there may be legal options at your disposal. Contact Sokolove Law today to learn more about pursuing a mesothelioma settlement.
Asbestos
Actos Lawsuit Report
Actos Lawsuit News – 5/3/2012: If you were prescribed Actos and have suffered negative side effects, please contact us today so that we can put you in touch with an attorney to advise you of your legal rights.
Actos Lawsuit: The United States Food and Drug Administration issued a Safety Announcement on June 15th 2011 warning the public about a link between the drug Actos and Bladder Cancer. This warning has led to the investigation of a new Actos Lawsuit by attorneys across the United States. This is not the first type of Actos Lawsuit that has been investigated and filed on behalf of people who have been injured by the use of Actos. This latest Actos Lawsuit centers around the link between Actos and Bladder Cancer. If you took Actos and later developed Bladder Cancer please contact us today so that we can make arrangements for a free consultation with an Actos Attorney regarding your potential Actos Lawsuit.
Bladder cancer, or any serious potentially life threatening illness is generally alien to most individuals. Suddenly, lives are changed and a new reality must be dealt with. Becoming a “patient” or worse “a cancer patient” is not only threatening, but a dreaded proposition. Cancer patients are not happy with the loss of autonomy, the invasion of privacy, the discomfort inflicted upon them and the demands on their time and quality of life. As a patient, being thrust into this altered identity, it is essential to seek out the information you need. Having a fundamental base of knowledge is a must when facing the issues and treatment decisions which lie ahead. Understanding bladder cancer is a tremendous first step that will assist you in your treatment. Having a qualified urologist administer the actual treatments and care for you is essential for the best possible outcome.
Actos Lawsuit News: More information about your search
Actos Lawsuit: Make sure you have an excellent urologist supervising your care. A urologist is a surgical specialist trained to care for conditions involving the male and female urinary tracts and the male reproductive system. The bladder is part of the urinary system, and a urologist is trained to care for problems involving it, including cancer. A urologist board certified by The American Board of Urology has gone through an accredited urology training program (generally a four year program), following two years of internship and residency in surgery after four years of medical school. The urologist must be in practice after training and provide a detailed list of surgeries, including complications, over a twelve month period. The doctor will then take a two day oral and written test covering a wide spectrum of urology. If he passes, he is certified for a period of ten years. At the end of the ten year period, he must recertify to maintain his board status. Recertification entails a three month surgical and procedure log and a written test as well as reference letters from those in a position to judge the practicing urologist’s work. Any malpractice or judgments are also reviewed. Although being board certified does not guarantee you have an excellent urologist, it demonstrates that he has the fund of knowledge to practice urology competently. Even though board certification is voluntary, in today’s competitive environment more and more hospitals and insurance plans are requiring their specialists to be certified.
Surgery is a skill which can only be mastered with experience. The saying “practice makes perfect” definitely pertains to surgery. Although a urology training program offers the new physician years of training, his surgical skills will continue to improve with further experience. However, each individual physician has his own innate skills. Some more quickly learn and are simply better at the technical craft of surgery than others. For the most part, urologists finishing an accredited urology program have the training and skill set required to care for patients with bladder cancer.
Actos Lawsuit News: Additional Information and Resources
Actos Lawsuit: Experience also counts. As a physician practices the art of medicine, his depth of knowledge and ability to treat grows. Ask your physician how long he has been treating patients with bladder cancer. If you require major surgery ask how many he has performed and if his complication rate matches what is expected. Physicians by and large do improve as they practice, and all physicians are required to show that they are continuing to learn by partaking in continuing medical education, a requirement to remain licensed. Most physicians are compulsive in their medical practice and care deeply in the care they deliver. They continually strive to improve. Some physicians may become “burned out” over the years as they continue to face the pressures of a busy medical practice. Similarly, towards the end of a surgeon’s career, technical skills may slip due to aging. New urologists are trained in the latest techniques and are familiar with recent medical literature, but may lack practical experience. In the end, recommendations from others and reputation may be your best guide to finding a qualified physician.
Our use of the term or terms Actos Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Actos Lawsuit visit our site often.
Yaz Class Action Release
Yaz Class Action: Two major studies have now addressed the validity and clinical importance of these observations. The first, the Pravastatin Inflammation/CRP Evaluation (PRINCE) trial, was explicitly designed to address three questions. First, can the effects of pravastatin on CRP observed in the CARE trial be confirmed in a direct hypothesis-testing setting? Second, how quickly does any effect of pravastatin on CRP occur and are the effects of pravastatin on CRP truly independent of changes in LDLC? And third, are the effects of pravastatin on CRP observed in CARE (a secondary-prevention study) equally present in primary- prevention populations? In total, the PRINCE trial evaluated 2884 patients: 1182 in a secondary- prevention cohort who received pravastatin 40 mg daily, and 1702 in a primary- prevention cohort randomly allocated to either pravastatin 40 mg daily or placebo. Prior use of lipid-lowering therapy within the previous 6 months was not allowed, and those in the primary-prevention arm had to have LDL cholesterol levels greater than 130 mg/dL. Blood samples were collected at baseline.
As ensured by the randomization process, baseline levels of CRP (median 0.20 mg/dL), total cholesterol (231 mg/dL), LDL cholesterol (143 mg/dL), and HDL cholesterol (40 mg/dL) were virtually identical in the two primary- prevention arms of the PRINCE trial. In contrast, compared with those in the primary-prevention cohort, those with a prior history of cardiovascular disease who were enrolled in the secondary-prevention cohort of PRINCE had significantly increased CRP levels (median 0.26 mg/dL). As would be expected, those in the secondary-prevention cohort were also older and more likely to smoke or have diabetes, and the group had a higher proportion of aspirin users than the primary-prevention cohort. During the course of the study, highly significant reductions in total cholesterol, LDL cholesterol, and triglycerides were observed in the pravastatin groups, as was a clinically important increase in HDL cholesterol (all p values <0.001). No change was observed in any of these parameters among those allocated to placebo.
The PRINCE study thus prospectively confirmed in a large community- based population that statin therapy lowers CRP, and that this effect cannot be predicted by the magnitude of LDL reduction. In addition to pravastatin, similar data in smaller studies have also been presented for cerivastatin, simvastatin, and atorvastatin although one study failed to show such an effect for fluvastatin. Nonetheless, evidence that statins lower CRP does not by itself provide a rationale for broader use of this therapy in primary prevention. However, very recent data from the AFCAPS/TexCAPS CRP substudy suggest that measurement of CRP may provide a novel method to improve the targeting of statin therapy.
However, lovastatin therapy was also effective in reducing the risk of first-ever coronary events among study participants with low levels of LDL cholesterol who had above-average levels of CRP. Specifically, the magnitude of risk reduction associated with statin use for those with above-average CRP levels but normal lipid levels was almost identical to that observed among those with above-median cholesterol levels. Moreover, among such patients who had elevated levels of CRP but normal lipid levels, the event rate was just as high as that observed among those with overt hyperlipidemia. For these individuals, the number- needed-to-treat was also very low (NNT = 48). By contrast, lovastatin appeared to have no effect in participants in AFCAPS/TexCAPS who had below-average LDL levels and below-average CRP levels. As might be expected, the absolute event rate was very low in this group, who had normal to low lipid levels and no evidence of inflammation. In this low-risk population defined by both LDL and CRP, the NNT was exceptionally large and statin utility cost-ineffective. Finally, like the PRINCE study, the AFCAPS/TexCAPS CRP substudy showed that lovastatin reduced CRP levels in a lipid-independent manner, this time at 1- year follow-up.
Our use of the term or terms Yaz Class Action is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Yaz Class Action News visit our site often.
Yaz Class Action
Doe Establishes Regulations to Protect Workers From Asbestos
There is still so much concern surrounding asbestos exposure and the increased risk of developing diseases such as mesothelioma that it causes that the Department of Energy (DOE) has taking steps to prevent construction workers from ending up near the loose fibers.
Mesothelioma Lawsuits: According to the Mid-Columbia Tri-City Herald, the DOE and its regulators have agreed to restrict allowance of heavy equipment to be used during the demolishing of buildings that still have asbestos products in them. The primary reason for the restriction was to protect the health of the construction workers who have to man the equipment during the process and could be exposed to asbestos in the process.
The decision from the DOE comes months after an early-warning report issued by the inspector general of the Environmental Protection Agency regarding workers conducting asbestos removal projects in Hanford, WA that could be unsafe. Prior to the warning, many workers had been performing asbestos abatement projects either by hand or by using heavy equipment.
Since the warning, Hanford contractors have not demolished any buildings that contain asbestos.
Asbestos Settlement: If you or a loved one has developed mesothelioma after being exposed to asbestos in the past, call Sokolove Law today to learn about your legal options regarding a mesothelioma lawsuit.
Asbestos
EPA Assessment on Asbestos Safety in Libby Due Within a Year
Mesothelioma and Asbestos: The Environmental Protection Agency has announced that a final Risk Assessment of the Libby Amphibole Asbestos will be completed in less than one year, hopefully providing some definitive answers on just how dangerous the mesothelioma-causing fibers are for those in the town of Libby, Montana.
According to The Western News, The EPA’s Libby Team Leader Victor Ketellapper recently told the Lincoln County Commissioners that a Risk Assessment on asbestos that was mined in Libby may be available sooner than expected.
“We do not have all the toxicity values (necessary), but when we do there will be a Risk Assessment, probably within a year,” he said. He added that the toxicity values should be made available by the Science Advisory Board in approximately six months, and the assessment would be released after they were properly analyzed.
Mesothelioma Law: Vermiculite ore contaminated with asbestos was mined in Libby for much of the 20th century. Out of approximately 2,600 residents of Libby, more than 200 people have died from diseases such as mesothelioma that can be linked to asbestos exposure.
If you or a loved one has been exposed to asbestos and now suffers from mesothelioma, contact Sokolove Law today for a free legal consultation regarding a mesothelioma lawsuit.
Asbestos
Yaz Settlement News Flash
Yaz Settlement: Another way to get estrogen to the vagina and bladder is to use an estrogen ring (Estring). The estrogen ring is a small silicone ring that is inserted in the vagina. The ring contains a very small amount of estrogen that is released slowly over ninety days. The ring can be left in place continuously and does not need to be removed for any activity, including exercise, bathing, or intercourse. Along the same lines, Vagifem is a small estrogen tablet that is easily inserted into the vagina with an applicator twice a week. The tablet sticks to tire vaginal wall and releases small amounts of estrogen over a few days. With either of diese methods, the dose of estrogen is low and virtually none is absorbed into the bloodstream. As a result, virtually no estrogen makes its way to the heart, bones, uterus, or other cells of the body, and no progesterone is needed to protect the uterine lining. The downside is that because the dose of estrogen is low, it may take longer to work. However, once the cells are healthy again, these methods are more convenient to use than the cream.
Urgency incontinence can often be treated with just a small dose of one of several medications. Some of the oral medications that are used for urgency incontinence are oxybutynin (Ditropan), imipramine (Tofranil), hyoscya- mine (Levsin), and tolterodine (Detrol). As with most medications, there are some possible side effects. All may cause dry mouth, dry skin, constipation, or blurry vision. If these side effects occur, the dose of medication can be lowered. Tolterodine, a newer medication, is very effective and may produce fewer side effects. Both tolterodine and oxybutynin are now available in once-a-day doses, which makes taking the medication easier.
There are other medications—imipramine and doxepin are examples-—-that not only reduce bladder spasms but also help keep the muscles in the urethra closed. They were initially prescribed in high doses to combat depression, but by chance researchers discovered that low doses of the same medication often helped with urgency incontinence. There is no connection between depression and urgency incontinence; the medications simply seem to help both. These medications can be used alone or in combination, depending on individual circumstances. All require a prescription and medical supervision, so you should discuss their use with your doctor. Newer medications are being developed all the time, and it is a good idea to ask your doctor about what might be newly available to help you.
In rare cases, these decongestants may also cause increased blood pressure or rapid heartbeat. Avoid them if you have high blood pressure. Other similar and frequently used drugs for stress incontinence are phenylpropanolamine (Omade, Dimetapp), which are prescription drugs and must be supervised by your doctor. If you are postmenopausal, using estrogen in combination with these medications may help improve their effectiveness. Mixed incontinence is a combination of urgency incontinence and stress incontinence. The bladder wall has spasms, and the sphincter muscles are weak and cannot prevent leaking. Thus, this type of incontinence requires a dual solution in the form of a combination of the types of medications described above. A drug that relaxes the bladder wall muscle is used in conjunction with a drug that keeps the bladder sphincter closed. Estrogen is also usually added in postmenopausal women to keep the tissues more elastic and healthier.
Yaz Settlement
EPA Awards Grant to Remove Asbestos From Oklahoma Schools
The Environmental Protection Agency (EPA) has given the Oklahoma Department of Labor (ODL) more than $230,000 to help facilitate the process of removing asbestos from state schools that may be putting students and teachers at an increased mesothelioma risk.
The ODL will receive the $234,713 in the grant, which was formally awarded by EPA this week, that it will use to fund inspections encourage compliance with the state’s Asbestos in Schools Program.
Asbestos Settlements: The EPA details the Asbestos in Schools program as a “designed to protect the health of school children and other occupants as well as the community.” Asbestos was used in the construction products that schools built in the 20th century contain. Even with asbestos abatement strategies in place for decades now, students and teachers are still exposed to dangers levels of asbestos at schools, and therefore have a higher risk of eventually developing mesothelioma.
If you or a loved one wish to file for mesothelioma compensation following a diagnosis, contact Sokolove Law today to learn more about how to properly pursue a mesothelioma claim by speaking with an attorney today.
Asbestos
Famous Buildings With Asbestos Put Visitors at Risk For Mesothelioma
Asbestos, the deadly mineral which can cause several diseases such as mesothelioma, was used widely in construction projects throughout most of the 20th century all over the world. The material was prized for its ability to reduce the risk of fires and act as effective insulation in large buildings.
Many of our nation’s greatest landmarks were built with asbestos products. While some of them have had the asbestos materials removed over time, many still contain some products that still may pose a health risk to the people who work in and visit these structures.
The United States Capitol complex is connected by a series of underground tunnels, many of which are lined with asbestos. In 2006, during maintenance operations in these tunnels, workers were exposed to the asbestos materials.
“The Happiest Place on Earth” used asbestos as part of its numerous indoor building projects before the park opened in 1971. Much of this material was removed in the late 1980s and early 1990s. It is rumored that asbestos still in the Polynesian Hotel.
3. Gateway Arch
The Gateway Arch in St. Louis, Missouri, built in the early 1960s, was found to contain asbestos materials in the early 1990s. Those materials have since been removed.
When Lady Liberty was under construction in France, Gustav Eiffel used asbestos to try to limit the long-term wear on the world-famous statue.
5. The Pentagon
It should come as no surprise that the headquarters of the American military would contain asbestos as the shipbuilding industry supporting the U.S. Navy in the middle of the 20th century was one of the largest single causes of asbestos exposure domestically.
In the boiler room of the iconic Old Faithful Inn in Yellowstone National Park, employees were subjected to deplorable conditions including loose asbestos insulation.
7. National Air and Space Museum
One of the most popular tourist attractions in the nation’s capital, the Smithsonian’s National Air and Space Museum has asbestos materials built into its walls.
Little known to most visitors, the Lincoln Memorial has a large basement where pipes are insulated with asbestos materials.
The site of the signing of the Declaration of Independence and the Constitution was forced to close temporarily in 1997 to remove asbestos.
Asbestos was used in several construction projects at the launching point for the American space program, which was largely developed in the 1950s and 1960s. These monuments, complexes and buildings represent only a small sampling of the buildings across this country that used asbestos as a construction material for one reason or another.
Asbestos Exposure: Individuals whose lives have been touched by mesothelioma may have various questions and concerns. If you or a loved one have been diagnosed with mesothelioma or asbestos cancer and need help, call our convenient toll-free number 888-360-4215 to speak with a mesothelioma consultant.
Mesothelioma
Yaz Side Effect Bulletin
Yaz Side Effect: The muscles that He directly below the vagina and encircle the rectum are the muscles that control bowel movements. During the final phases of labor, when the baby is pushed through the vagina, these muscles are subjected to enormous forces and pressures. As a result, injury may occur. Just as for urinary incontinence, there is a higher likelihood of anal incontinence in a woman following a vaginal delivery than following a cesarean section. Studies show that more than a third of women who deliver vaginaHy have some damage to die anal muscles. In women who have undergone a forceps delivery, about 80 percent have damage to the anal muscles. Injured nerves can also be found in these women. Most recover their prelabor function, but for some the damaging effects can persist for years. The result of severe injury to the anal muscles and nerves can be the inability of the anal muscle to close entirely, with resultant involuntary loss of gas or stool.
Just before the delivery of the baby’s head, an incision may be made by the doctor in the skin, and sometimes also in the muscle, in the bottom portion of the vagina to allow more room for the baby to deliver. This incision, called (midline) episiotomy, is supposed to avoid incidental tearing of the vagina or rectum as the baby delivers. Episiotomy is a recent practice, devised in order to substitute a straight, clean, easy-to-repair surgical incision for the jagged tear that might otherwise occur. This incision is also intended to shorten labor by giving the baby’s head more room so delivery can be easier and faster. It was previously thought that faster delivery would decrease the risk of injury to the mother’s bladder and would be gender on the baby’s head. However, studies have shown no evidence tiiat these assumptions are true.
Recent studies, performed by ultrasound to measure these muscles right after deliver)’’, have shown that much more damage occurs than was previously assumed. Since this is an area of concentrated research, new techniques to both recognize and repair any muscle damage should be forthcoming. We imagine that in the future obstetricians might use an ultrasound machine in the delivery room to show any postdelivery injuries to the rectum and vagina and make necessary repairs immediately. We hope this will make prolapse and incontinence less likely in the future. Currently, there are no easily available means to determine if any nerves have been damaged by a delivery, and unfortunately, there is still no way of repairing damaged nerves.
However, most women who deliver vaginally remain continent, so no one is proposing that all women have cesarean sections in order to avoid the possibility of later incontinence. We dearly do not understand all the factors that determine who will develop incontinence, so cesarean section is not necessary in many women with long or difficult labors. With our present understanding, many women would have to have cesareans in order to prevent one woman from developing incontinence. In addition, cesarean section has its own risks, including bleeding and the possible need for transfusion, the possibility of infection, and the risks of anesthesia and surgical injury to the bladder or intestines. The prolonged discomfort and recovery from a cesarean section at a time when the mother wants to be focused on caring for her baby are also not in anyone’s best interest.
Yaz Side Effect
High School Basketball Player Not Held Back By Erbs Palsy
Landus Anderson is one of the top high school basketball players in Florida and has aspirations to one day play basketball in college and beyond. All the more impressive is that he accomplishes everything he does on the court with only one hand due to the fact that he has Erb’s Palsy.
According to the Fort Wayne Journal Gazette, the 6-4 junior who has averaged more than 19 points and eight rebounds a game for the Florida High Seminoles has no control of his fingers on his right hand. Similarly, his right arm can hardly be used in competition either. While some children diagnosed with Erb’s Palsy can recover range of motion in their arm by their first birthday, such was not the case with Anderson.
Cerebral Palsy: “They can’t fix the damaged nerves, but at birth I had a muscle transfer in my bicep area,” said Anderson, who is almost a straight-A student as well. “They could’ve done one down low, but my mother didn’t want them to experiment on me.”
Despite his birth injury, Anderson has learned through the years to accomplish everything from the most simple skills (tying a shoe) to more complicated ones (playing basketball) with the help of his family.
“He has a determination that’s so unique,” his mother Pamela Anderson told the Journal Gazette. “He’s not a complainer. He’s not a whiner. It wasn’t easy, but Landus made it easier.”
While a birth injury such as Erb’s Palsy can be very difficult with, it is possible for people with the condition to live regular lives. If you have a child who was born with a birth injury that may have been cause by medical negligence, contact Sokolove Law today to learn more about possibly pursuing a birth injury lawsuit.
Birth injury infographic brought to
you by Sokolove Law
Erbs Palsy
Yaz Class Action Statement
Yaz Class Action: Alternatively, the possibility of direct contributions from CRP in athero- genesis and acute arterial thrombosis should be considered. CRP has been found within atherosclerotic lesions and is known to stimulate the expression of tissue factor, influence leukocytes , and activate complement. Notably, the lack of association between hs-CRP elevation and the burden of coronary atherosclerosis assessed either angiographically or with electron- beam computed tomography (180) support the notion that hs-CRP levels instead reflect pathobiological properties of the atheroma and vascular endothelium (i.e., plaque vulnerability rather than severity). Recent studies demonstrating an association between elevated hs-CRP and endothelial dysfunction determined in studies of human forearm blood flow lend additional credence to this argument. Further investigation directed at elucidating the precise relationships between the elevation of acute-phase reactants, cytokines, and intercellular adhesion molecules and adverse cardiovascular prognosis will continue to advance.
If inflammatory markers such as hs-CRP are to become useful in clinical practice, there must be evidence that they add to the prognostic information offered by traditional cardiovascular risk factors. In the case of hs-CRP, baseline elevation of the inflammatory marker remains highly predictive of future events after adjustment for traditional risk factors including age, hypertension, diabetes, body mass, index, and smoking status. When used in conjunction with lipid measurements in the Women’s Health Study and Physicians Health Study, hs-CRP added to the predictive information offered by the total to high-density cholesterol ratio (TC:HDL). Moreover, in a prospective evaluation in healthy women that compared traditional (TC and TC : HDL) as well as several ‘‘novel’’ (lipoprotein(a), homocysteine, hs-CRP) markers of cardiovascular risk, the combination of hs-CRP and the TC : HDL ratio was found to be the strongest predictor of first myocardial infarction.
Although the epidemiological data supporting the prognostic utility of hs-CRP are strong and consistent, the inflammatory marker is unlikely to carry significant impact on clinical strategies for management of atherosclerotic vascular disease if the associated risk cannot be modified by available therapies. Thus, data suggesting important interactions between hs-CRP and specific pharmacological therapies are of particular clinical as well as experimental interest.
Aspirin, an agent with both antiplatelet and anti-inflammatory effects, was the first specific pharmacological therapy tested for CRP interaction. In the Physicians Health Study, participants were randomly assigned to low-dose aspirin (325 mg p.o. q.o.d.) or placebo with a 44% reduction in the risk of first MI associated with aspirin use (p < 0.001). However, in a nested case control analysis, stratification by quartiles of baseline hs-CRP revealed an increasing gradient of benefit with aspirin, such that those in the highest quartile of hs-CRP realized a 55.7% (p = 0.002) reduction in the risk of first MI compared with 13.9% (p = 0.77) among those in the lowest quartile of hs-CRP concentration. Similar differential effects of aspirin on clinical outcomes in the presence or absence of elevated CRP levels has recently been reported in the setting of unstable angina. Indeed, in this setting, the prognostic value of CRP was found to be quite limited once patients had been treated with aspirin. These data suggest that at least part of the benefit of aspirin may result from an interaction with underlying low-grade vascular inflammation. To date, however, data have been conflicting as to whether aspirin use reduces CRP levels. Whether other COX-1 and/or COX-2 inhibitors impact upon CRP levels is currently under investigation.
Yaz Class Action
Januvia Attorneys
Januvia Attorneys News – 5/2/2012: Did you take Januvia? Please contact us today if you took Januvia and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.
Januvia Attorneys: As long as a nest of tumor cells remains small—less than a millimeter in diameter—it can depend on diffusion to solve its logistical problems of supply and elimination. Molecules released by die cancer cell or its normal neighbors can diffuse over this short distance quite effectively. But once the clump of cells reaches die one millimeter size, it bumps up against a limit, a glass ceiling. Now the process of diffusion can no longer provide an adequate flow of nutrients and oxygen and a rapid removal of wastes. Soon, cells within the clump become starved and begin to choke on their own wastes. Such anoxic cells often die from mediated apoptosis.
The death rate of these cells from asphyxiation and metabolic poisoning begins to approach the rate at which these cells can regenerate themselves. Any gains made through cell proliferation are neutralized by attrition, and so the size of this tumor cell clump remains constant. Some microscopic nests of tumor cells may remain in this static state for years, possibly even decades. To become threatening, these nests of tumor cells must break out of their futile cycles of division followed by starvation and asphyxiation. Such escape demands that the cells within these nests become truly creative: They must invent a better way of accessing nutrients and voiding wastes.
Their solution lies in developing their own blood circulation system. While the small band of tumor cells has survived half-starved, its normal neighbors nearby have all along enjoyed a reliable supply of nourishment and oxygen because of their close connections with die body’s circulatory system. Unlike the small nest of tumor cells, normal tissue is interlaced with a dense network of capillaries. Often the array of capillaries is so dense that every cell in a tissue has direct access to an adjacent capillary. These small vessels, just wide enough to allow red blood cells to pass in single file, supply all metabolically active tissues throughout the body and carry off their wastes.
To grow beyond the one-millimeter limit, a nest of cancer cells must invent a way to recruit capillaries into its midst. A surgeon in Boston, has spent the past two decades uncovering the cancer cells’ strategy. Some cells in the clump, aping the normal cells around them, acquire the ability to secrete growth factors that attract endothelial cells from nearby tissue and induce these cells to multiply. Capillaries grow into the clump of cancer cells. Finally, the tumor cell clump has acquired direct access to oxygen- and nutrient-rich blood. Now this nest of cells can take off. Their proliferative agenda, frustrated for so many years, can now be fulfilled. Their numbers begin to increase explosively.
Januvia Attorneys News: More information about your search
Januvia Attorneys: The growth factors released by these cancer cells are often called “angiogenic factors” because they encourage angio-genesis, the construction of blood vessels. These factors include VEGF and bFGF (basic fibroblast growth factor). The eventual success of the nest of tumor cells is closely tied to its ability to induce angiogenesis. Should members of this clump begin to elaborate high levels of angiogenic factors, their descendants, months later, will form tumors that are densely interlaced with capillaries; these cancers are often destined to grow aggressively and spread widely. Tumors that have poorly developed capillary networks are more indolent, and patients carrying such tumors usually have a much better prognosis. Indeed, some physicians use the presence or absence of dense capillary networks in tumor samples to determine the stage of tumor development and to predict its future course.
A tumor mass one centimeter in diameter may contain as many as a billion cells. At first glance, the number seems huge, but it pales next to the number of cells in the body as whole—more than ten thousand times more. So a cancer this size is rarely life-threatening. In most places in the body, it probably will not compromise die functioning of a vital organ. Most tumors need to be far larger before they become lethal. Of those patients who succumb to cancer, fewer than 10 percent die from tumors that continue to grow at the same site where they originally took root. In the great majority of cases, die killers are the metastases—colonies of cancer cells that have left the site of the original, primary tumor and have settled elsewhere in the body. It is these migrants, or rather the new tumors that they seed, that usually cause death.
Januvia Attorneys News: Additional Information and Resources
Januvia Attorneys: The major insight afforded by this revolution is that cancer is a disease of damaged genes. We now know the identities of many of the culprit genes—oncogenes and tumor suppressor genes. They control the behavior of the cells in which they operate; the cells respond in turn by generating tumors. To be sure, many cancer-related genes still remain to be identified and isolated by gene cloning. The means by which many genes influence cell behavior also remain to be discovered. We know that the agents that provoke human cancer promote, directly or indirectly, the creation of mutant genes. We know that the appearance of a human tumor requires a succession of mutations, each responsible for perturbing a distinct cellular growth-controlling gene. And we know that processes that threaten the integrity of the cell genome, including defects in its maintenance and repair, strongly influence the rate at which cancers appear.
The discovery of various growth-controlling genes has provided us with a view of the complex decision-making circuitry that lies within each human cell. Biologists have cataloged the diverse behaviors of cells for more than a century. Cell behavior seemed to have its own logic, determined by submicroscopic vital forces hidden deep within. We now understand that logic in terms of critical signal-processing proteins that determine the cell’s responses to a wide variety of stimuli; these proteins assemble to form an elaborate signal processing circuitry. Every week new pieces are added to the wiring diagram of this circuitry. Its design—its interconnections and the actions of its component parts—determines how cells behave. Knowledge of this circuitry will provide the ultimate answers for those interested in understanding cancer. There are no deeper or more subtle mechanisms hiding in some secret corner of the cell. The answers are all there, or will be found there shortly. Two decades ago, we knew nothing of all this.
Major reductions in cancer mortality will derive from identifying and eliminating discrete causes of the disease— in particular, certain aspects of diet and lifestyle. Much of this job is the purview of the epidemiologists. Indeed, we have already learned much from them. They have framed the problem, defined its scope, breadth, and depth. They also have disabused us of a couple of notions widespread in some circles: that the industrialized West is being inundated with a cancer epidemic, and that most of this inundation is traceable to chemical pollutants in the air and in the food chain. Almost all cancer deaths in the United States were caused by tobacco. The obvious response—reduction in tobacco usage—has already shown its effectiveness: By 1990, the century-long increase in lung cancer death rose in men was reversed. Without the contribution of lung cancer, the overall age-adjusted death rate from cancer would have declined 14 percent between 1950 and 1990.of this age-adjusted increase in cancer deaths flows directly from tobacco consumption.
Our use of the term or terms Januvia Attorneys is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Januvia Attorneys News visit our site often.
Byetta Attorneys Report
Byetta Attorneys News – 5/2/2012: Byetta may be linked to serious negative side effects. If you took Byetta and believe you suffered negative side effects as a result, contact us today so that we can make arrangements for a free consultation with a law firm that is investigating cases related to the side effects of Byetta.
Byetta Attorneys: The explosive growth of genetics in the twentieth century showed that all organisms, including even simple single-cell organisms such as bacteria and baker’s yeast, rely on genes as the templates for making progeny. Also, virtually all organisms, ranging from bacteria to humans, were found to have evolved elaborate mating mechanisms. In every case, the same underlying motive was apparent: Mating enabled the exchange and mixing of genes between members of a species. Since all species comprised populations of genetically heterogeneous individuals, mating afforded the opportunity of testing novel combinations of genes. Novel gene combinations might yield offspring that were more fit than their parents. That increased fitness, in turn, powered the engine of evolution.
Controlled mating of genetically distinct individuals became a powerful tool for studying the behavior of genes—in particular, how the genes carried by one parent in a mating blended with those of its partner. While bacteria and yeast cells were found to mate with one another, cells prepared from mammalian tissues lacked that ability. The only matings naturally allowed between mammalian cells involved the fusion of sperm and egg. These facts prevented researchers from observing the outcome of mating dissimilar kinds of cells—bone cells from one person with bone cells from another, or bone cells with muscle cells of the same person.
Under some conditions, these fusions could involve dozens of cells simultaneously, yielding enormous cells that were far too large and unwieldy to grow and divide. Far more interesting were the fusions involving only pairs of cells. Such two-cell hybrids could grow and divide, transmitting to offspring the pooled genes originating from the two parent cells. The outcome of these hybridizations seemed obvious. Cancer is a dominating force in the body, and tumor cells invariably grow more vigorously than their normal counterparts. Therefore, if a cancer cell was fused to a normal cell, the potent genes in the cancer cell would dominate over the weaker genes carried by its normal partner. The hybrid cell carrying both sets of genes should, by this logic, behave like the cancerous parent. Among other things, this hybrid cell should be able to seed tumors when injected into a mouse or rat.
The genes present in the normal cells seemed to be slowing down growth. They acted, in effect, like brakes that allowed cells to counteract any tendencies to lurch forward into runaway growth. Cancer cells, having lost these genes, had lost their braking mechanism. Once the braking mechanism was reinstalled in the cancer cells by the cell hybridization trick, the cancer cells’ forward momentum ground to a lialt. Now these runaways had a means of controlling the uncontrollable—their drive to grow without limit.
Byetta Attorneys News: More information about your search
Byetta Attorneys : Now there were two groups of genetic actors on the cancer stage, each specifying a distinct part of the machinery that governed cell growth. The proto-oncogenes operated like the accelerator pedal in a car; mutant oncogenic versions of these genes seemed to result in pedals that were stuck to the floor. Conversely, the tumor suppressor genes worked like brakes. As normal cells developed into cancer cells, they might shed or inactivate these tumor suppressor genes, resulting in defective braking mechanisms. Runaway cell growth seemed to be explainable by either mechanism.
The existence of two diametrically opposite explanations of cancer formation demanded some resolution. Did some kinds of tumor cells rely on one mechanism to achieve malignant growth while others used the alternative mechanism? Or did both mechanisms operate together within cancer cells? Perhaps stuck accelerators and faulty brakes conspired to create cancerous growth. The answers to these questions did not fall in place immediately. But the discovery of tumor suppressor genes did open the door to another aspect of human cancer—its heritability. Cancer often runs in families, and these genes provided an explanation for the origin of many kinds of familial cancer.
Byetta Attorneys News: Additional Information and Resources
Byetta Attorneys: But the most convenient and therefore most frequently used way for a cell to rid itself of a gene is more subtle. Most often, a gene will suffer only a single base change—a point mutation—in one of its sequences. Such a subtle change may have deadly consequences if it strikes a critical sequence in the gene. Point mutations may insert inappropriate punctuation marks into the middle of a gene; because these marks normally signal the end of a gene, they may terminate the read-out of the gene prematurely, causing truncation of the protein specified by this gene. Other times, the protein product of the gene may suffer some change in its string of amino acids that renders it nonfunctional. The result of all these mutations, large and small, will be the same: The cell will lose the services of the mutated gene.
In reality, losing the services of a tumor suppressor gene is more complicated than implied here. Almost all genes in our cells are present in two redundant copies, one deriving originally from our mother’s genes, the other from our father. In the case of tumor suppressor genes, this two-copy system offers a measure of protection to the cell. If one copy of a suppressor gene is accidental lost, the remaining gene copy serves as a perfectly adequate backup. Almost always, half a brake lining is as good as a whole one in slowing down cell growth.
Tumor cells usually resort to a more expedient way of eliminating the second copy of a tumor suppressor gene. Their strategy depends on the fact that the two partners in a human chromosome pair (such as the two thirteenth chromosomes, each of which carries an Rb gene copy) often line up next to one another in parallel array, look each other over, compare their respective DNA sequences, and then swap genetic information. One frequent result is that a gene sequence present on one chromosome will now replace the corresponding sequence carried by its partner. Before this information transfer, two distinct versions of a gene may have resided on the two paired chromosomes; afterward, one of these versions is lost, being replaced by a duplicated version of the gene originally present on the other chromosome. The result is two identical copies of a gene in a cell that previously carried two dissimilar versions.
Our use of the term or terms Byetta Attorneys is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Byetta Attorneys News visit our site often.
Byetta Class Action Top News
Byetta Class Action News – 5/2/2012: Did you take Byetta? Please contact us today if you took Byetta and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.
Byetta Class Action: Tumor cells usually resort to a more expedient way of eliminating the second copy of a tumor suppressor gene. Their strategy depends on the fact that the two partners in a human chromosome pair (such as the two thirteenth chromosomes, each of which carries an Rb gene copy) often line up next to one another in parallel array, look each other over, compare their respective DNA sequences, and then swap genetic information. One frequent result is that a gene sequence present on one chromosome will now replace the corresponding sequence carried by its partner. Before this information transfer, two distinct versions of a gene may have resided on the two paired chromosomes; afterward, one of these versions is lost, being replaced by a duplicated version of the gene originally present on the other chromosome.
Precancerous tumor cells on their way to becoming actively malignant will often use this trick to eliminate both copies of a tumor suppressor gene that has been holding back their growth. They will first mutate to inactivity one copy of the gene and then eliminate its partner through this loss-of-heterozygosity homogenization. Importantly, the chromosomal swaps that generate this homogenization often involve large regions of the chromosome surrounding the tumor suppressor gene, not just the gene itself. Hundreds of genes residing to the left and the right of the tumor suppressor gene on a chromosome will also become homogenized. Of course, the homogenization of neighboring gene copies is irrelevant for the growth of the developing tumor cells. These neighboring genes are nothing more than innocent bystanders. It is realty only the tumor suppressor gene that the tumor cell is intent on eliminating through use of the homogenization trick.
Two things changed in modern times. We now live much longer than we used to. By the middle of the twentieth century, many of us began to live for seventy or eighty years, an age when this disease strikes frequently. A hundred years earlier, relatively few survived long enough to confront it. Our diet also changed from one heavy in grains and vegetables to fare that increasingly emphasized meat and large amounts of fat. The effects of diet are apparent from epidemiology: There are regions of Africa whose inhabitants follow a diet based almost exclusively on vegetables and grains. These people run a risk of colon cancer that is less than one-tenth of that seen in the West.
Byetta Class Action News: More information about your search
Byetta Class Action: Some humans make these detoxifying enzymes at high levels, while others produce them at much lower levels. These differences, which are heritable, offer us the opportunity to understand the roles of these enzymes in protecting cells against attack by various carcinogens. For example, do individuals with low levels of these protective enzymes contract cancer more often than those having high levels? In fact, some striking differences have been uncovered. Smokers who make low levels of the NAT enzyme (N-acetyl transferase) run as much as two and a half times the risk of bladder cancer compared to smokers having high levels of the NAT enzyme. Low levels of a second detoxifying enzyme, GSTMl (glutathione-S-transferase Ml), result in a threefold increase in the risk of lung cancer. These findings suggest that we may one day be able to calculate smokers’ risk of cancer based on their lifelong cigarette consumption and their levels of detoxifying enzymes.
Some mutagens succeed in penetrating this complex array of protective devices. Having escaped inactivation, these mutagens may proceed to react with and thereby damage the DNA molecules carried in the cell’s chromosomes. Every human cell sustains thousands of such mutagenic attacks every day. But in spite of this barrage, the cell’s DNA emerges at the end of the day relatively unscathed. This discrepancy demands explanation.
Close scrutiny of the machinery used by the cell to copy its DNA molecules reveals a similar discrepancy. The process by which cells replicate DNA in preparation for cell division is prone to error. Immediately after DNA polymerase—the enzyme responsible for DNA replication—has copied a stretch of DNA, as many as one in every thousand bases of the newly made DNA strand may be incorrect, having been mistakenly inserted by the polymerase. But as before, the actual rate at which mutations accumulate in the DNA is much lower. Somehow, the vast majority of these initial copying mistakes are not perpetuated in the DNA.
This dynamic has direct consequences for tumor formation: If the DNA repair process fails, large numbers of altered bases will accumulate in a cell’s DNA. This means that the rate at which mutations accumulate is influenced by at least three distinct processes: damage inflicted on the DNA by mutagens of foreign or internal origin, mistakes made during DNA copying, and defects in die DNA repair machinery responsible for erasing the damage created by mutagens or miscopying. Since mutation is the engine that drives tumor progression, all three of these processes are likely to be involved in one way or another in causing cancer.
Byetta Class Action News: Additional Information and Resources
Byetta Class Action: Knowing about mutant genes allows us to trace the roots of cancer back to discrete, identifiable changes in the central controlling molecule of the cell, its DNA. But in one sense, these genetic discoveries are sterile and uninformative. Genes are pure information, nothing more than mathematical abstractions. Studied in isolation, they tell us little about the real life of the cell. Moreover, the sequence of DNA bases that constitutes a gene usually reveals little about how this gene operates. So, even after we know that one or another gene is mutated during the development of a cancer, we still understand next to nothing about the mechanisms by which this mutant gene causes abnormal cell growth. Fortunately, molecular biology provides us with a useful train of logic that leads us toward an understanding of gene function. Genes instruct the cells around them to make specific proteins. It is the proteins that do the work of the genes. Proteins catalyze biochemical reactions or create elaborate physical structures. To understand how a gene works, we must know intimately how its protein functions.
In one sense, the roles played by the normal versions of oncoproteins are obvious: They help the normal cell regulate its growth. Unfortunately, this statement does not take us very far; it only restates the problem, and in a way that is not terribly useful. A more productive tack is suggested by the following question: Precisely how do normal cells know when to grow and when to hold back from growth? At any moment, the great majority of cells in our body are in a quiescent state. Only in tissues that renew themselves constantly, such as the colonic epithelium, the bone marrow (which generates new blood cells), and the skin, does one find large numbers of cells actively growing and dividing.
These dramatic differences in the proliferation rates of tissues bring us back to our question: Precisely how do any of these cells know when they should grow? The issue becomes even more complicated in the case of embryonic development, where cell proliferation results in the creation of new, complex tissues rather than the maintenance of an existing tissue architecture.
Our use of the term or terms Byetta Class Action is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Byetta Class Action News visit our site often.
Januvia Attorney
Januvia Attorney News – 5/1/2012: If you were prescribed Januvia and have suffered negative side effects, please contact us today so that we can put you in touch with an attorney to advise you of your legal rights.
Januvia Attorney: As long as a nest of tumor cells remains small—less than a millimeter in diameter—it can depend on diffusion to solve its logistical problems of supply and elimination. Molecules released by die cancer cell or its normal neighbors can diffuse over this short distance quite effectively. But once the clump of cells reaches die one millimeter size, it bumps up against a limit, a glass ceiling. Now the process of diffusion can no longer provide an adequate flow of nutrients and oxygen and a rapid removal of wastes. Soon, cells within the clump become starved and begin to choke on their own wastes. Such anoxic cells often die from mediated apoptosis.
The death rate of these cells from asphyxiation and metabolic poisoning begins to approach the rate at which these cells can regenerate themselves. Any gains made through cell proliferation are neutralized by attrition, and so the size of this tumor cell clump remains constant. Some microscopic nests of tumor cells may remain in this static state for years, possibly even decades. To become threatening, these nests of tumor cells must break out of their futile cycles of division followed by starvation and asphyxiation. Such escape demands that the cells within these nests become truly creative: They must invent a better way of accessing nutrients and voiding wastes.
Their solution lies in developing their own blood circulation system. While the small band of tumor cells has survived half-starved, its normal neighbors nearby have all along enjoyed a reliable supply of nourishment and oxygen because of their close connections with die body’s circulatory system. Unlike the small nest of tumor cells, normal tissue is interlaced with a dense network of capillaries. Often the array of capillaries is so dense that every cell in a tissue has direct access to an adjacent capillary. These small vessels, just wide enough to allow red blood cells to pass in single file, supply all metabolically active tissues throughout the body and carry off their wastes.
To grow beyond the one-millimeter limit, a nest of cancer cells must invent a way to recruit capillaries into its midst. A surgeon in Boston, has spent the past two decades uncovering the cancer cells’ strategy. Some cells in the clump, aping the normal cells around them, acquire the ability to secrete growth factors that attract endothelial cells from nearby tissue and induce these cells to multiply. Capillaries grow into the clump of cancer cells. Finally, the tumor cell clump has acquired direct access to oxygen- and nutrient-rich blood. Now this nest of cells can take off. Their proliferative agenda, frustrated for so many years, can now be fulfilled. Their numbers begin to increase explosively.
Januvia Attorney News: More information about your search
Januvia Attorney: The growth factors released by these cancer cells are often called “angiogenic factors” because they encourage angio-genesis, the construction of blood vessels. These factors include VEGF and bFGF (basic fibroblast growth factor). The eventual success of the nest of tumor cells is closely tied to its ability to induce angiogenesis. Should members of this clump begin to elaborate high levels of angiogenic factors, their descendants, months later, will form tumors that are densely interlaced with capillaries; these cancers are often destined to grow aggressively and spread widely. Tumors that have poorly developed capillary networks are more indolent, and patients carrying such tumors usually have a much better prognosis. Indeed, some physicians use the presence or absence of dense capillary networks in tumor samples to determine the stage of tumor development and to predict its future course.
A tumor mass one centimeter in diameter may contain as many as a billion cells. At first glance, the number seems huge, but it pales next to the number of cells in the body as whole—more than ten thousand times more. So a cancer this size is rarely life-threatening. In most places in the body, it probably will not compromise die functioning of a vital organ. Most tumors need to be far larger before they become lethal. Of those patients who succumb to cancer, fewer than 10 percent die from tumors that continue to grow at the same site where they originally took root. In the great majority of cases, die killers are the metastases—colonies of cancer cells that have left the site of the original, primary tumor and have settled elsewhere in the body. It is these migrants, or rather the new tumors that they seed, that usually cause death.
Januvia Attorney News: Additional Information and Resources
Januvia Attorney: The major insight afforded by this revolution is that cancer is a disease of damaged genes. We now know the identities of many of the culprit genes—oncogenes and tumor suppressor genes. They control the behavior of the cells in which they operate; the cells respond in turn by generating tumors. To be sure, many cancer-related genes still remain to be identified and isolated by gene cloning. The means by which many genes influence cell behavior also remain to be discovered. We know that the agents that provoke human cancer promote, directly or indirectly, the creation of mutant genes. We know that the appearance of a human tumor requires a succession of mutations, each responsible for perturbing a distinct cellular growth-controlling gene. And we know that processes that threaten the integrity of the cell genome, including defects in its maintenance and repair, strongly influence the rate at which cancers appear.
The discovery of various growth-controlling genes has provided us with a view of the complex decision-making circuitry that lies within each human cell. Biologists have cataloged the diverse behaviors of cells for more than a century. Cell behavior seemed to have its own logic, determined by submicroscopic vital forces hidden deep within. We now understand that logic in terms of critical signal-processing proteins that determine the cell’s responses to a wide variety of stimuli; these proteins assemble to form an elaborate signal processing circuitry. Every week new pieces are added to the wiring diagram of this circuitry. Its design—its interconnections and the actions of its component parts—determines how cells behave. Knowledge of this circuitry will provide the ultimate answers for those interested in understanding cancer. There are no deeper or more subtle mechanisms hiding in some secret corner of the cell. The answers are all there, or will be found there shortly. Two decades ago, we knew nothing of all this.
Major reductions in cancer mortality will derive from identifying and eliminating discrete causes of the disease— in particular, certain aspects of diet and lifestyle. Much of this job is the purview of the epidemiologists. Indeed, we have already learned much from them. They have framed the problem, defined its scope, breadth, and depth. They also have disabused us of a couple of notions widespread in some circles: that the industrialized West is being inundated with a cancer epidemic, and that most of this inundation is traceable to chemical pollutants in the air and in the food chain. Almost all cancer deaths in the United States were caused by tobacco. The obvious response—reduction in tobacco usage—has already shown its effectiveness: By 1990, the century-long increase in lung cancer death rose in men was reversed. Without the contribution of lung cancer, the overall age-adjusted death rate from cancer would have declined 14 percent between 1950 and 1990.of this age-adjusted increase in cancer deaths flows directly from tobacco consumption.
Our use of the term or terms Januvia Attorney is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Januvia Attorney News visit our site often.
Byetta Attorneys
Byetta Attorneys News – 5/1/2012: Did you take Byetta? Please contact us today if you took Byetta and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.
Byetta Attorneys: The explosive growth of genetics in the twentieth century showed that all organisms, including even simple single-cell organisms such as bacteria and baker’s yeast, rely on genes as the templates for making progeny. Also, virtually all organisms, ranging from bacteria to humans, were found to have evolved elaborate mating mechanisms. In every case, the same underlying motive was apparent: Mating enabled the exchange and mixing of genes between members of a species. Since all species comprised populations of genetically heterogeneous individuals, mating afforded the opportunity of testing novel combinations of genes. Novel gene combinations might yield offspring that were more fit than their parents. That increased fitness, in turn, powered the engine of evolution.
Controlled mating of genetically distinct individuals became a powerful tool for studying the behavior of genes—in particular, how the genes carried by one parent in a mating blended with those of its partner. While bacteria and yeast cells were found to mate with one another, cells prepared from mammalian tissues lacked that ability. The only matings naturally allowed between mammalian cells involved the fusion of sperm and egg. These facts prevented researchers from observing the outcome of mating dissimilar kinds of cells—bone cells from one person with bone cells from another, or bone cells with muscle cells of the same person.
Under some conditions, these fusions could involve dozens of cells simultaneously, yielding enormous cells that were far too large and unwieldy to grow and divide. Far more interesting were the fusions involving only pairs of cells. Such two-cell hybrids could grow and divide, transmitting to offspring the pooled genes originating from the two parent cells. The outcome of these hybridizations seemed obvious. Cancer is a dominating force in the body, and tumor cells invariably grow more vigorously than their normal counterparts. Therefore, if a cancer cell was fused to a normal cell, the potent genes in the cancer cell would dominate over the weaker genes carried by its normal partner. The hybrid cell carrying both sets of genes should, by this logic, behave like the cancerous parent. Among other things, this hybrid cell should be able to seed tumors when injected into a mouse or rat.
The genes present in the normal cells seemed to be slowing down growth. They acted, in effect, like brakes that allowed cells to counteract any tendencies to lurch forward into runaway growth. Cancer cells, having lost these genes, had lost their braking mechanism. Once the braking mechanism was reinstalled in the cancer cells by the cell hybridization trick, the cancer cells’ forward momentum ground to a lialt. Now these runaways had a means of controlling the uncontrollable—their drive to grow without limit.
Byetta Attorneys News: More information about your search
Byetta Attorneys : Now there were two groups of genetic actors on the cancer stage, each specifying a distinct part of the machinery that governed cell growth. The proto-oncogenes operated like the accelerator pedal in a car; mutant oncogenic versions of these genes seemed to result in pedals that were stuck to the floor. Conversely, the tumor suppressor genes worked like brakes. As normal cells developed into cancer cells, they might shed or inactivate these tumor suppressor genes, resulting in defective braking mechanisms. Runaway cell growth seemed to be explainable by either mechanism.
The existence of two diametrically opposite explanations of cancer formation demanded some resolution. Did some kinds of tumor cells rely on one mechanism to achieve malignant growth while others used the alternative mechanism? Or did both mechanisms operate together within cancer cells? Perhaps stuck accelerators and faulty brakes conspired to create cancerous growth. The answers to these questions did not fall in place immediately. But the discovery of tumor suppressor genes did open the door to another aspect of human cancer—its heritability. Cancer often runs in families, and these genes provided an explanation for the origin of many kinds of familial cancer.
Byetta Attorneys News: Additional Information and Resources
Byetta Attorneys: But the most convenient and therefore most frequently used way for a cell to rid itself of a gene is more subtle. Most often, a gene will suffer only a single base change—a point mutation—in one of its sequences. Such a subtle change may have deadly consequences if it strikes a critical sequence in the gene. Point mutations may insert inappropriate punctuation marks into the middle of a gene; because these marks normally signal the end of a gene, they may terminate the read-out of the gene prematurely, causing truncation of the protein specified by this gene. Other times, the protein product of the gene may suffer some change in its string of amino acids that renders it nonfunctional. The result of all these mutations, large and small, will be the same: The cell will lose the services of the mutated gene.
In reality, losing the services of a tumor suppressor gene is more complicated than implied here. Almost all genes in our cells are present in two redundant copies, one deriving originally from our mother’s genes, the other from our father. In the case of tumor suppressor genes, this two-copy system offers a measure of protection to the cell. If one copy of a suppressor gene is accidental lost, the remaining gene copy serves as a perfectly adequate backup. Almost always, half a brake lining is as good as a whole one in slowing down cell growth.
Tumor cells usually resort to a more expedient way of eliminating the second copy of a tumor suppressor gene. Their strategy depends on the fact that the two partners in a human chromosome pair (such as the two thirteenth chromosomes, each of which carries an Rb gene copy) often line up next to one another in parallel array, look each other over, compare their respective DNA sequences, and then swap genetic information. One frequent result is that a gene sequence present on one chromosome will now replace the corresponding sequence carried by its partner. Before this information transfer, two distinct versions of a gene may have resided on the two paired chromosomes; afterward, one of these versions is lost, being replaced by a duplicated version of the gene originally present on the other chromosome. The result is two identical copies of a gene in a cell that previously carried two dissimilar versions.
Our use of the term or terms Byetta Attorneys is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Byetta Attorneys News visit our site often.
Mesothelioma Update
Mesothelioma: Far away from the corporate boardrooms in New York and London, workers toiled to produce asbestos fiber. One of the peculiarities of asbestos is that it tends to be mined in beautiful places. The Cassiar mine in British Columbia and the Libby Mine in Montana are set like ‘jewels’ in the North American mountain wilderness. Chrysotile Arizona was established at the bottom of Ash Creek Canyon, in the shimmering desert area east of Phoenix. The Shabanie mine in Zimbabwe is surrounded by conical hills, which could have been lifted from a Ming dynasty painting. The now deserted Penge mine in South Africa is adjacent to the Kruger National Park and nestles in the midst of steep hills which are cut through by the Oliphants River. The bleached landscape around Kuruman in the Northern Cape is offset by the blue Asbestos Mountains where ‘eyes’ of subterranean water form striking oases. Havelock in Swaziland lies in the midst of spectacular mountains and forests. The long-abandoned Wittenoom mine in the Pilbara region of Western Australia is framed by intense blue skies, bright red earth, and the hauntingly beautiful ghost gums which line the Wittenoom Gorge. Such physical beauty forms a sharp contrast to the work conditions on the mines and the impact of mining upon the health of local communities.
Asbestos miners faced many of the same problems as other miners, including low rates of pay, dangerous conditions, and intractable management. There are in addition technical factors which make asbestos mining particularly hazardous. Although the methods of extracting asbestos ore have varied from open-cut to depth-mining, the aim of processing fiber is always the same, namely to preserve the mineral’s physical properties. For that reason asbestos is milled dry. After arriving at a mill, ore is fed into primary crushers, then crushed and sorted.
In 1878, mining began at Thetford in Canada, but the methods of extraction were primitive and returns depended upon the richness of the ore. The Canadian mines were mostly open-cut and the covering soil, which was up to twenty feet thick, had to be removed in summer; in winter the ground froze. Quarry mining appealed to management as it required no ventilation or timbering and offered easier supervision of the workforce. There were no such advantages for labor and from November to April the men who toiled in the quarries were exposed to snow and ice. Most of the cobbing or hand processing was done on contract by teams of women who were paid between 30 and 35 cents per hundred-weight. The cost of labor was so low that a tonne of fiber could be cobbed for less than $8. The Canadian mines enjoyed the advantage of proximity to the huge US market thereby avoiding the freight costs which hit Southern African and Russian producers. Initially, only long fibers, which accounted for around 2 per cent of Canadian output, were bagged and the remaining ‘shorts’ were discarded. The discovery that short fibers could be combined with pulp to make asbestos paper, with cement to make shingles, or magnesia to make insulation, revolutionized the market.
Mesothelioma
Mesothelioma Lawyers News
Mesothelioma Lawyers News – 3/5/2012: More information about your search
Mesothelioma Lawyers: Exposure to asbestos is the link to the development of mesothelioma. People who end up with this disease usually have had some type of previous exposure to asbestos. How this works is not fully understood. It is thought that asbestos fibers are inhaled and first travel through the upper air passages, which include the throat, the trachea (windpipe), and the large bronchi (large breathing tubes of the lungs). These airways are lined with mucus, and therefore most of the fibers are cleared from these upper airways by sticking to this mucus and being coughed up or swallowed. When the fibers continue to travel and reach the small airways (the alveoli), the body’s immune system is able to surround, engulf, and remove the smaller fibers by a process known as phagocytosis.
Malignant mesothelioma is a rare form of cancer that is found m the lining of the chest and lung (the pleura), the abdomen (the peritoneum), or the saclike space around the heart (the pericardium). Although it is rare, mesothelioma is a very serious disease that is often at an advanced stage when the diagnosis is made. In the United States an estimated 2000 to 3000 new cases of mesothelioma are diagnosed each year. Approximately three fourths of these cases start in the chest cavity and are called pleural mesotheliomas. Another 10% to 20% begin in the abdomen and are called peritoneal mesotheliomas. Lastly, those that start in the lining around the heart are called pericardial mesotheliomas, but these are extremely rare.
In America, asbestosis compensation cases began in 1927 when a Massachusetts asbestos textile worker filed a claim. A group of Johns- Manville workers launched claims in 1929 and by the mid-1930s at least sixty-nine more state compensation suits were brought against the company. During the 1930s, claims were filed against other leading manufacturers, such as Raybestos-Manhattan. The latter compensated about twenty cases in the 1930s, with average payments between $2,000 and $3,000, sometimes less. But it was no more than a trickle of cases. The low numbers reflected the lack of state coverage and the fact that the American system was adversarial, involving the court system. Insurers rarely accepted liability without a legal fight. It also reflected the stringency of compensation legislation. Here, too, many claims were ‘statute- barred’, so that workers could not claim if they had left the industry more than a year or had worked in more than one state. This was an especially cruel limitation for insulators with their itinerant work practices.
Selikoffs activities in Canada ended abruptly when the Quebec industry was nationalized, but before then trade union agitation at Thetford had triggered a federal inquiry. Published in 1976, it found that dust control was very poor and the lead investigator, Judge René Beaudry, found it ‘shocking’ that in some plants workers were still handling asbestos fiber with their bare hands. He went on to comment on employers: ‘They have kept available information about the dangerous effects of asbestos dust away from the workers and the unions.’ A similar picture was drawn by an Asbestosis Working Group in Ottawa, which suggested that McDonald’s statistics on mesothelioma were underestimated. These reports concluded that the industry was more concerned with medicalizing the asbestos problem through the compensation system and epidemiology than by spending money on protecting workers from the dust. Revelations were also emerging of poor working conditions at the Canadian plants of Johns-Manville in Scarborough, T&N in Montreal, and Bendix Automotive in Windsor.
Mesothelioma Lawyers
Tekturna Lawsuit Information
Tekturna Lawsuit: Just behind the brain stem, and slightly above it, sits the cerebel”lum, a mass of tissue that coordinates our every movement. It helps us keep our balance, allowing us to hold a glass of water steady. The cerebellum also coordinates the movements of our speech muscles. Working with the cerebellum are the basal ganglia, located in the higher parts of the brain, helping to smooth the way we move. Obviously, a stroke in either of these two areas of the brain can affect our balance and our movements.
This locale of the brain is the gateway to the higher-functioning areas of the brain. Situated right above the brain stem, the dien”cephalon is home to two crucial vice presidents. The thalamus is a relay station that sorts out the messages traveling to the brain and decides which areas get what. It might send a message to several areas of the brain at once. When you step on a nail, for example, the pain will shoot through your brain stem to your thalamus and on to your memory storage bank. You might remember when you were a kid and had to get a tetanus shot because you stepped on a rusty nail.
Look in the mirror. Imagine a line going straight down the middle of your head, dividing it into two perfectly similar mirror images. Indeed, it’s as if there were a line dividing your brain into perfect halves. We call these exact replicas the right and left hemispheres of the brain. Despite the use of “right brain-left brain speak” by pop psychologists to help people find everything from their “in”ner selves” to great relationships, there are very real—and differ”ent—functions for each hemisphere.
Tekturna Lawsuit
Januvia Lawyer
Januvia Lawyer News – 4/30/2012: If you were prescribed Januvia and have suffered negative side effects, please contact us today so that we can put you in touch with an attorney to advise you of your legal rights.
Januvia Lawyer: Cancer wreaks havoc in almost every part of the human body. Tumors strike the brain and the gut, muscles and bones. Some grow slowly; others are more aggressive and expand quickly. Their presence in human tissues signals chaos and a breakdown of normal function. Cancer brings unwelcome change to a biological machine that is perfect, marvelously beautiful, and complex beyond measure. Wherever tumors appear, they take on the appearance of alien life forms, invaders that enter the body through stealth and begin their programs of destruction from within. But appearances deceive: The truth is much more subtle and endlessly interesting.
Tumors are not foreign invaders. They arise from the same material used by the body to construct its own tissues. Tumors use the same components—human cells-—to form the jumbled masses that disrupt biological order and function and, if left unchecked, to bring the whole complex, life- sustaining edifice that is the human body crashing down. How are human tissues put together from single cells? The description above might suggest the involvement of master builders who oversee crews of workers, directing them in the detailed construction of normal and malignant tissues. In reality, there are no overseers forcing throngs of cells to line up and assemble themselves into normal or cancerous tissues. Architectural complexity in living tissue comes from the bricks themselves, the individual cells. Control is exercised from the bottom up.
Normal and malignant cells know how to build. Each carries its own agenda that tells it when it should grow and divide and how it should aggregate with other cells to create organs and tissues. Our bodies are nothing more than highly complex societies of rather autonomous cells, each retaining many of the attributes of a fully independent organism. Right there, we confront great beauty and profound danger. The beauty lies in the coordinated behavior of so many cells to create the single, highly functional cooperative that is the human body. The danger lies in the absence of a single overseeing master builder, which seems to put the whole enterprise at great risk. Granting autonomy to trillions of worker cells invites chaos. When, as usually happens, these cells are well behaved and public-spirited, extraordinarily complex order ensues. But on occasion, a cell may choose to go its own way and invent its own novel version of a tissue or organ. It is then that we see the much-feared chaos that we call cancer.
Januvia Lawyer News: More information about your search
Januvia Lawyer: Most human tumors comprise a billion or more cells before we become aware of them. The cells within a tumor differ from their normal counterparts in many respects, exhibiting distinctive shapes, growth properties, and metabolism. The sudden appearance of such a horde of cells would seem to reflect some recent mass conversion, in which millions of normal cells enlisted overnight in the ranks of a tumor mass. Once again, appearances deceive. The creation of a tumor is an extraordinarily slow process, often extending over decades. The cells forming a tumor are all lineal descendants of a single progenitor, a distant ancestor that lived many years before the tumor mass became apparent. This founder, this renegade cell, decided to go off on its own, to begin its own growth, program within one of the body’s tissues. Thereafter, its proliferation was controlled by its own internal agenda rather than the needs of the community of cells around it.
So there were no millions of recruits, only a single one that spawned a vast horde of like-minded descendants. The billions of cells in a tumor are cast in the image of their renegade ancestor. They have no interest in the well-being of the tissue and organism around them. Like the founder cell, they have only one program in mind: more growth, more replicas of themselves, unlimited expansion. The chaos they create makes it clear how very dangerous it is to entrust each cell in the human body with its own measure of independence. Still, that is how we are put together, and how all complex, many-celled organisms have been designed for the past 600 million years. Learning this, we realize that the chaos of cancer is not a modern affliction but a risk run by all multicellular organisms, from ancient to modern. Indeed, given the trillions of cells in the human body, is it not a wonder that cancer does not erupt often during our long lives?
The notion that cancer was not a random, spontaneous degeneration of the body’s tissues, but instead was actively induced, radically changed the thinking of many cancer researchers. If external agents triggered die disease, perhaps they could be identified and their mechanisms of action studied. Perhaps the entire process from the initial encounter with a cancer-causing agent to the appearance of a cancer could be uncovered. So, toward the end of the nineteenth century, scientists throughout the world tried to recreate cancer in laboratory animals—mice, rats, and rabbits. For years, all such attempts failed.
The first successes came in Japan in the first decade of die new century. Katsusaburo Yamagiwa took instruction from the far earlier studies of European chimney siveeps. Percival Pott’s initial observations of high rates of scrotal cancer in London chimney sweeps had been followed several decades later by the work of others who found that chimney sweeps on the Continent had much lower rates of this tumor. The difference seemed to be related to personal hygiene practices. The British chimney sweeps, like many of their eighteenth-century countrymen, rarely took baths, while the chimney sweeps on the Continent bathed frequendy. It seemed that creosote tars from the London flues stuck to the skin of die British sweeps and triggered cancer unless washed away quickly.
Our use of the term or terms Januvia Lawyer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Januvia Lawyer News Update visit our site often.
Byetta Attorneys Bulletin
Byetta Attorneys: But the most convenient and therefore most frequently used way for a cell to rid itself of a gene is more subtle. Most often, a gene will suffer only a single base change—a point mutation—in one of its sequences. Such a subtle change may have deadly consequences if it strikes a critical sequence in the gene. Point mutations may insert inappropriate punctuation marks into the middle of a gene; because these marks normally signal the end of a gene, they may terminate the read-out of the gene prematurely, causing truncation of the protein specified by this gene. Other times, the protein product of the gene may suffer some change in its string of amino acids that renders it nonfunctional. The result of all these mutations, large and small, will be the same: The cell will lose the services of the mutated gene.
In reality, losing the services of a tumor suppressor gene is more complicated than implied here. Almost all genes in our cells are present in two redundant copies, one deriving originally from our mother’s genes, the other from our father. In the case of tumor suppressor genes, this two-copy system offers a measure of protection to the cell. If one copy of a suppressor gene is accidental lost, the remaining gene copy serves as a perfectly adequate backup. Almost always, half a brake lining is as good as a whole one in slowing down cell growth.
Tumor cells usually resort to a more expedient way of eliminating the second copy of a tumor suppressor gene. Their strategy depends on the fact that the two partners in a human chromosome pair (such as the two thirteenth chromosomes, each of which carries an Rb gene copy) often line up next to one another in parallel array, look each other over, compare their respective DNA sequences, and then swap genetic information. One frequent result is that a gene sequence present on one chromosome will now replace the corresponding sequence carried by its partner. Before this information transfer, two distinct versions of a gene may have resided on the two paired chromosomes; afterward, one of these versions is lost, being replaced by a duplicated version of the gene originally present on the other chromosome. The result is two identical copies of a gene in a cell that previously carried two dissimilar versions.
Our use of the term or terms Byetta Attorneys is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Byetta Attorneys News visit our site often.
Byetta Attorneys
Mesothelioma Lawyers Action
Mesothelioma Lawyers: Beginning in the 1960s, dust control became a major battleground between government, industry, and the trade unions. Until that time, the global industry had been unregulated, in the sense that no country had set a legally enforceable dust threshold. Dust controls on the South Africa mines, for example, were virtually non-existent. In the US and Europe, dust control in the asbestos-using industries—especially lagging and building work—was also lacking (essentially because the nature of the work meant that dust could not be controlled within the confines of ships, power stations, and high-rise blocks). In most of the asbestos factories in the US and Europe, dust control was scarcely more impressive. In a few factories in the UK (which was probably the world leader in dust control), dust extraction limited some of the worst effects, so that workers found they could see their mates through the haze of the workshops. But even in these factories, some areas were unregulated and workers were offered little protection, apart from inadequate masks. Anyone who worked with asbestos was breathing fibers; so too were asbestos users outside the factories.
The industry leaders gradually developed a range of building and insulation products. Johns-Manville first entered the market with stove and boiler insulation and later branched into theater curtains and movie- projection booths. Most fire curtains were clearly labeled ‘asbestos’ to reassure audiences about their safety. In 1899 an Austrian chemist, Ludwig Hatschek, discovered how to combine asbestos with cement and the mineral soon became popular as a reinforcing agent. The next major innovations were brake linings and friction materials for automobiles. Scottish industry was among the first in Western Europe to adopt asbestos for shipbuilding and heavy engineering. The mineral was initially imported from Canada in 1871. Before the end of that decade, the Scottish Asbestos Company, which made engine packing and insulation, was operating its own mines in Quebec. By 1885 there were nineteen manufacturers and distributors in Glasgow alone; a decade later there were fifty-two. In Scotland, as elsewhere, work conditions in factories and shipyards were shaped by rapacious employers, weak trade unionism, and negligent regulatory authorities.
Asbestos was present in cement sheeting which clad many homes and in the pipes which supplied water; asbestos fibre was blended into vinyl floor tiles and in insulation designed to make oil refineries, hospitals, warships, cinemas, and domestic dwellings safe. It was used in rubber and plastic products, mixed with adhesives, cements, paints, and sealants. In automobiles asbestos was blended into gaskets, cylinder heads, spark plug washers, exhaust pipe insulation, radiator blankets, and brake linings. Some of its more exotic uses included cigarette filters, dish towels, surgical thread, banknotes, piano felts, ironing boards, berets, aprons, carpets, tampons and filters for rice, salt, beer, and fruit juice. In the 1920s, one British manufacturer sold mattresses filled with crocidolite or blue asbestos promising that their customers could with safety smoke in bed. The US postal service used asbestos mail bags. At one time toothpaste was fortified with fiber. The burning broomstick of the Wicked Witch in The Wizard ofOz was made from asbestos and the artificial snow in Citizen Kane was probably chrysotile. Asbestos was also a common ingredient in talcum powders, where it found its way into condoms. During the twentieth century, sufficient asbestos cement (a/c) pipe was manufactured in the US alone to circle the earth eight times and still run to the moon and back.
Mesothelioma Lawyers
Pradaxa Recall Process
Pradaxa Recall: Before the clot or deposit disappears, symptoms may appear. As with a completed stroke, the symptoms of TIA also depend on the area of the brain where the blood supply was interrupted. Unfortunately, because these symptoms disappear, sometimes within minutes, they are often ignored. Furthermore, because they are often vague or mild, we quickly ignore them. After all, who wants to believe that they could be having a stroke? But therein lies the danger of TIA. Yes, its symptoms fade, but the underlying mechanisms that created it still are hidden within our bodies. Blood still can be filled with cholesterol. Artery walls still can be vulnerable. Clots still can be forming.
Temporary weakness, numbness, or paralysis of the hand, arm, leg, or face on one or both sides of the body. These are the most crucial “red flag” symptoms. They are not only the most common characteristics of TIA, but if immediately brought to your physician’s attention, they can save your life. One note: this weakness or numbness is not the same thing as the “pins and needles” you feel when, for example, your foot falls asleep. It comes on quickly and leaves just as fast. Sudden blurred, dimmed, or complete loss of vision in one or both eyes that lasts longer than a few seconds. Sudden loss of vision in one eye can signal an embolus to the main artery to the eye, and the loss of vision in both eyes can be the result of inadequate blood flow to the occipital lobes.
Speech, and language difficulties. This can involve having trouble actually speaking and understanding the spoken word (aphasia) or the written word (alexia). Slurred or “thick” speech (dysarthria) is a sign of a vertebrobasilar TIA, which is a TIA in the arteries at the back of the brain. Lack of coordination or balance. Technically, this condition is yet another A term: ataxia. It can involve arms or legs— resulting in difficulty holding a glass or walking. It is a sign of vertebrobasilar insufficiency.
Pradaxa Recall
Asbestos Dumped in Canadian Town Angers Residents
A Canadian mayor’s decision to allow a Montreal company to leave asbestos debris in the town’s dump has many residents both angry and concerned for their health.
Mesothelioma: The CBC recently reported on the situation in Gilliam, Manitoba, where Mayor Jim Goymer struck a deal with a Montreal environmental company to dispose of 540 tons of non-hazardous contaminated soil and 410 tons of asbestos materials within the town borders.
While the initial loads of waste were left in the community dump in bags that identified them as a “Cancer and Lung Disease Hazard,” many of the town’s residents are nonetheless angry that the deadly materials were allowed into their town in the first place.
“You go and dump a bunch of big bags marked ‘Caution, Danger, Cancer-causing Lung Disease Agents,’ and then don’t expect people to freak out? They give us no pre-warning, they never gave us the choice as to letting this happen,” said Julie Crawford, a resident who lives nearby the dump.
Cases of Mesothelioma: Additionally, photos have been taken by town residents showing that some of the bags had been slit open and were spilling out grey powder, potentially releasing loose asbestos fibers into the air in the process.
If you or a loved one have been diagnosed with mesothelioma after previously being exposed asbestos fibers, contact Sokolove Law today to learn more about potentially pursuing a mesothelioma lawsuit.
Asbestos
Yaz Blood Clots Report
Yaz Blood Clots: The procedure: Commonly called an “echo,” this test uses sound waves to produce moving images of the beating heart. This is usually conducted as a painless outpatient procedure, although at times there can be some mild discomfort as the echo probe is pushed against your skin. The echo shows the size, shape, and position of your heart’s structures. It also detects and measures blood flow across the heart’s valves and pressure within its chambers. An echocardiogram provides much important information to your cardiologist and can be repeated over time to make comparisons.
How it’s done: An echo can be performed at your doctors office or the hospital. After you lie down on an exam table, a technician or physician will apply several small, flat, sticky patches called electrodes to your chest, then place a probe on your chest. You will then be asked to lie to one side, placing your body in the right position for the best images to be recorded. Before the echo probe is placed on the outside of your chest, its tip is smothered with gel that helps improve the quality of the imaging. The probe sends and receives high-frequency ultrasound waves that are bounced off your heart. The echocardiogram equipment translates the sound waves into pictures, which reveal abnormalities.
The technician or physician will pause the video periodically to measure the heart and all of its structures, which enables the calculation of ejection fraction, stroke volume, and cardiac output. Doctors rely on these important measurements to decide whether your heart failure is stable, improving, or progressing. During the procedure you will, at times, hear the amplified sound of your heart beating. At the end, you will be given a towel to wipe the gel off your skin.
Be cautioned, though, that your ejection fraction number is not precise; in fact, it may vary by 5 percent to 10 percent—even on the same day. So rather than using your EF as the only indicator of your condition, be sure to ask your doctor for his or her opinion on your overall progress. Your physician will look at many variables, including the EF, to assess your condition. It’s important to remember that many patients experience no increase in their EF from their treatment. Nonetheless they feel much better, deriving great benefit from their prescribed medications together with the dietary, exercise, and lifestyle programs they embark upon.
There are, as you can see, many diagnostic tests and procedures available to help doctors accurately diagnose heart failure. Each provides a unique set of helpful information. As a result, it is quite common for cardiologists to use more than one so that they are able to build up a detailed picture of how the patients heart is functioning. As we age, our eyesight and hearing often worsen, joints become inflamed, skin loses elasticity, and bones turn more brittle. No part of the human body is impervious to aging, including the heart, which loses some of its blood-pumping capability.
Yaz Blood Clots
Byetta Lawyer
Byetta Lawyer News – 4/27/2012: Byetta may be linked to serious negative side effects. If you took Byetta and believe you suffered negative side effects as a result, contact us today so that we can make arrangements for a free consultation with a law firm that is investigating cases related to the side effects of Byetta.
Byetta Lawyer: Many cells that suffer only minimal damage and remain viable are nonetheless consigned to apoptotic death. At first glance, these suicides appear wasteful. Tissues dissipate valuable resources by continually creating new cells to replace those that, though only minimally defective, have been weeded out nonetheless. But in the end, this spending of resources represents a far smaller concern than the danger posed by the continued presence of a damaged, possibly mutant cell. This begins to suggest an important role of apoptosis in preventing cancer by rapidly eliminating errant cells scattered throughout the body’s tissues.
Subtle irregularities in the internal growth-regulating circuitry of cells can trigger the death program. Such irregularities may occur within cancer cells, associated with metabolic imbalances and inappropriate growth signaling. For example, the introduction of a myc oncogene into a normal cell seems to cause a signaling imbalance that provokes many cells to trigger their apoptotic death program. This suggests that many cells that have acquired a myc oncogene through some accidental mutation may be eliminated rapidly through apoptosis. A small minority of these cells may, through one strategy or another, evade the almost inevitable suicide program. Indeed, all cells may be hardwired to kill themselves in the event that an oncogene becomes activated within them. In effect, the body has set up trip wires in all its cells. These alarm devices constitute barriers to tumor formation by consigning incipient cancer cells to quick and certain death.
Byetta Lawyer News: More information about your search
Byetta Lawyer: In all types of human cancer, simple arithmetic determines whether or not premalignant cells will eventually succeed in creating a full-blown tumor. To form life-threatening tumors, cells must increase their ability to proliferate and, at the same time, find means of avoiding death. Some groups of premalignant cells may well succeed in increasing their rate of multiplication by acquiring an activated oncogene but may fail to address the threats of apoptosis and senescence; any gains they make through increased proliferation may be neutralized by equal or greater rates of cell death. The net result will be a cell population of constant or even diminishing size. Only when the problem of cell death is solved can such a cell population begin to expand rapidly, generating a Malthusian explosion.
For the incipient cancer cell, inactivating the gene through mutation has obvious benefits. Once a cell has knocked out its gene, this damage response pathway is crippled. As a consequence, this cell and its descendants can continue to proliferate even after sustaining substantial damage to their genomes. Lacking functional, these cells will race ahead and copy their still-damaged DNA, incorporating unrepaired lesions into the newly made genome replicas. Resulting mutant genomes will then be passed on to descendant cells.
Almost all kinds of tumor cells achieve immortalization, and inactivation aids in this process as well. Recall that the barrier to immortalization is telomere shrinkage and collapse. Once telomeres have shrunk to a small size, an initial alarm is sounded that tells cells to stop growing and enter into a senescent, nongrowing state. The shortened telomeres seem to be perceived by the cell as damaged DNA. It appears to be mobilized in response to this genetic emergency and responds, as usual, by shutting down cell growth. Such cells will remain in this static state for long periods of time and are said to be senescent.
Byetta Lawyer News: Additional Information and Resources
Byetta Lawyer: We now realize that anticancer therapies usually operate very differently. The doses of chemotherapeutics and X-rays that succeed in killing cancer cells do not in fact inflict massive destruction on their genomes. Instead, these treatments create just enough damage to activate and in turn the programmed cell death response. So cancer therapy does not succeed by bludgeoning cancer cells with a sledgehammer. Instead, it tweaks die cancer cells’ control machinery, nudging these cells over the line that separates normal growth from apoptotic death.
This explains why often a central player in determining the responsiveness of cells to anticancer therapy. As has been observed recently, cancer cells that have lost function are often more resistant to treatment, apparently because they are not readily coaxed into committing suicide. This may have substantial implications in the cancer clinic, where treatment strategies may soon be fine-tuned by knowing the status of the gene present in a patient’s tumor cells.
Every call needs a well-functioning brain, in effect an executive who sits in some central office, receives information from branch offices, weighs all options, and makes the tough decisions. In fact, the range of possible decisions made by the executive brain of a cell is limited—whether the cell should grow, or differentiate into a specialized cell type, or die. If these critical decisions are made improperly by individual cells, the well-organized communities of cells that form human tissues will disintegrate into unruly throngs, with each member cell veering off on its own capricious trajectory. While the output of this executive decision-making machinery is limited, the information that informs these decisions is highly complex, originating from dozens of sources. These include the external signals brought to the cell by growth factors, chemical interchanges with neighboring cells, and physical contacts with adjacent cells and with the proteinaceous matrix that surrounds many cells. In addition, there is a wealth of internal housekeeping information, including periodic status reports on the health of the cell’s DNA and the activity of the cell’s metabolic machinery.
Human cells in active growth may move through this cycle once each day, though some race through it much more rapidly. By regulating the forward motion of the cell around this life cycle (usually called the cell cycle), die cell cycle clock determines the fate of the cell. Not surprisingly, the operations of the cell cycle clock are disrupted in cancer cells. In these cells, the clock makes decisions that are, by normal standards, highly inappropriate. Instead of proceeding cautiously, carefully weighing the alternatives of growth and quiescence, the cell cycle clock will decide rashly and choose die growth option. In effect, the clock apparatus spins uncontrollably. Since it acts as Lbe master controller of the cell, the cell around it will respond by growing and dividing without limit.
Our use of the term or terms Byetta Lawyer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Byetta Lawyer News visit our site often.
Byetta Class Action News
Byetta Class Action: Tumor cells usually resort to a more expedient way of eliminating the second copy of a tumor suppressor gene. Their strategy depends on the fact that the two partners in a human chromosome pair (such as the two thirteenth chromosomes, each of which carries an Rb gene copy) often line up next to one another in parallel array, look each other over, compare their respective DNA sequences, and then swap genetic information. One frequent result is that a gene sequence present on one chromosome will now replace the corresponding sequence carried by its partner. Before this information transfer, two distinct versions of a gene may have resided on the two paired chromosomes; afterward, one of these versions is lost, being replaced by a duplicated version of the gene originally present on the other chromosome.
Precancerous tumor cells on their way to becoming actively malignant will often use this trick to eliminate both copies of a tumor suppressor gene that has been holding back their growth. They will first mutate to inactivity one copy of the gene and then eliminate its partner through this loss-of-heterozygosity homogenization. Importantly, the chromosomal swaps that generate this homogenization often involve large regions of the chromosome surrounding the tumor suppressor gene, not just the gene itself. Hundreds of genes residing to the left and the right of the tumor suppressor gene on a chromosome will also become homogenized. Of course, the homogenization of neighboring gene copies is irrelevant for the growth of the developing tumor cells. These neighboring genes are nothing more than innocent bystanders. It is realty only the tumor suppressor gene that the tumor cell is intent on eliminating through use of the homogenization trick.
Two things changed in modern times. We now live much longer than we used to. By the middle of the twentieth century, many of us began to live for seventy or eighty years, an age when this disease strikes frequently. A hundred years earlier, relatively few survived long enough to confront it. Our diet also changed from one heavy in grains and vegetables to fare that increasingly emphasized meat and large amounts of fat. The effects of diet are apparent from epidemiology: There are regions of Africa whose inhabitants follow a diet based almost exclusively on vegetables and grains. These people run a risk of colon cancer that is less than one-tenth of that seen in the West.
Byetta Class Action
Pradaxa Side Effects Statement
Pradaxa Side Effects: It’s called a thrombosis, the most common form of stroke. In fact, 80-85 percent of all strokes are ischemic in nature. Here, the blood flow in the brain, either deep in its interior or in the less deep carotid artery in the neck, is blocked because of a clot that forms in the artery. Atherosclerosis is its greatest influence. Think of it. Either through cholesterol deposits or aging, the in”side walls of the arteries become less flexible; thick deposits of fat form, and passageways become too narrow for blood to flow through smoothly. Instead, the blood forms a clot around these thick deposits as it tries to get past.
Ironically, these clots usually begin as a healthy measure. The deposits or rough places on the artery wall are seen by the body as a “call to arms,” a need to stave off infection. The blood, thinking these areas need repair, clots around them. Platelets send out their thin clotting fibers. Red and white blood cells join in the action. Soon, the clotting has a life of its own, acting like a net as it pulls platelets, red blood cells, even bits of floating cholesterol into its web. A scab can form, making the mass of cholesterol and blood even thicker.
This type of stroke, too, is caused by a clot. These embolic strokes are less common than their thrombotic cousin. But these clots, called emboli, are the traveling salespeople of stroke, a mass of tissue, blood, and cholesterol that originates somewhere else in our body, usually in the heart or the neck’s carotid artery, only to end up in the brain. Here, when the clotting action occurs, a piece of clot eventually breaks off. This clot, or embolism, is carried by the bloodstream to the brain, where the arteries are smaller. Soon, the clot gets stuck, literally plugging up the passageway beyond it. Blood simply cannot get past the embolism.
Our use of the term or terms Pradaxa Side Effects is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Pradaxa Side Effects visit our site often.
Pradax Side Effects
Yaz Class Action Important Info
Yaz Class Action: While data on aspirin are important pathophysiologically, the most provocative data regarding preventive medical therapy interacting with CRP involves the hy- droxymethylglutaryl coenzyme A reductase inhibitors, or ‘‘statins.’’ In this regard, experimental evidence has for some time supported the idea that, in addition to lowering LDL cholesterol, statins may have relevant anti-inflammatory and thus plaque-stabilizing effects. For example, statins have been shown to reduce macrophage content within atherosclerotic plaques, decrease neointimal inflammation, and suppress matrix metalloproteinase expression, all processes involved in the vulnerability of luminal plaque.
Clinical evidence demonstrating anti-inflammatory and plaque-stabilizing effects of statin drugs has only recently become available. The first study to address whether patients with evidence of inflammation benefited from statin therapy was performed within the Cholesterol and Recurrent Events (CARE) trial, a secondary-prevention evaluation of pravastatin. Consistent with studies of primary prevention, participants in the CARE trial with elevated CRP levels were found to have higher risks of recurrent coronary events than those with lower levels of CRP. However, a clinically apparent interaction between statin therapy and inflammation was also observed in that the proportion of recurrent events prevented by pravastatin was 54% among those with inflammation compared with 25% among those without inflammation.
Moreover, long-term therapy with pravastatin significantly reduced plasma levels of CRP in a manner that was not related to this agent’s effects on LDL cholesterol. In fact, in this hypothesis-generating study, there was no relationship between the change in CRP and the change in LDL cholesterol at the end of the 5-year follow-up period. Thus, these initial data provided clinical evidence that statin therapy may well have anti-inflammatory properties. While the mechanism of this effect is uncertain, the CARE data provide evidence for possible clinical relevance of laboratory observations demonstrating nonlipid effects of the HMG-CoA reductase inhibitors, such as modulation of immune function, antiproliferative effects on vascular smooth muscle, and antithrombotic properties, as well as morphological effects.
Indeed, taken together with data from animal studies demonstrating that both dietary and statin-induced lipid lowering result in reduction in metalloproteinase activity, the data from CARE serve to raise the possibility that statin therapy may achieve a reduction in cardiovascular events through both lipid-dependent and lipid-independent effects on inflammatory cell function and related plaque vulnerability. However, the hypothesis-generating data from CARE—while provocative and initially controversial—require direct evaluation in hypothesis-testing trials.
Yaz Class Action
Birth Injury Lawsuit Leads to $15 Million Award
Florida senators recently passed a new bill that will require a hospital to pay $15 million to the family of a boy who was born with cerebral palsy more 14 years ago, due to the medical negligence of its employees.
According to Herald Tribune, a jury found that the employees at the Lee Memorial Health System were negligent during the birth of Aaron Edward, which led to his birth injuries. The jury originally awarded close to $31 million to Edwards and his family but a state law hindered them from receiving the full amount. His attorneys proposed a bill that would force Lee Memorial to pay damages and it passed in a 32-4 vote.
Birth Injuries: Due to his injuries, Edwards needs physical care 24 hours a day and can communicated with the aid of a computer system.
If you have given birth to a child with cerebral palsy, contact Sokolove Law for a free legal consultation to find out if a birth injury lawyer may be able to help you.
Birth injury infographic brought to
you by Sokolove Law
Birth Injury
Yaz Lawyer Action
Yaz Lawyer: Right-sided heart failure: The right atrium receives blood as it returns to the heart through the veins. The right ventricle then pumps it into the lungs, where the blood picks up oxygen. When heart failure affects the right side of the heart, it becomes unable to pump sufficient blood to the lungs. As a result, the incoming blood backs up in the body’s veins, which often causes the ankles and legs to swell. Congestive heart failure: When the heart muscle fails, the kidneys may respond by retaining water and sodium in the body. As fluid builds up in the arms, legs, feet, lungs, or other organs, the body becomes congested. This condition is called congestive heart failure. Diastolic heart failure: This form gets its name because the problem happens during the diastole period of the heart’s activity: when the heart relaxes after a beat. The heart muscles stiffen and are unable to fill adequately with blood during the resting period, so the heart lacks sufficient blood to pump out. As the heart chamber thickens, there’s little room for the heart to relax, and blood backs up in the lungs. The blood pressure increases in the heart and lungs, causing shortness of breath. At first, this occurs only with exertion, but eventually, in severe cases, it happens when the person is at rest or with minimal activities, such as talking or dressing. Systolic heart failure: This type of heart failure acquires its name because of problems during the systole period of the heart’s activity, or when it is pumping blood out to the rest of the body The left ventricle heart muscle becomes unable to contract with enough vigor, so less oxygen-rich blood is delivered out into the arteries and pumped through the body. Systolic heart failure results in a reduced ejection fraction. This is the proportion of blood that leaves the heart each time it contracts. A normal ejection fraction is in the range of 55 percent to 65 percent. Patients with systolic heart failure typically have an ejection fraction of less than 50 percent and, in severe cases, as low as 10 percent to 15 percent.
Many patients with heart failure have both systolic and diastolic heart failure. Approximately 40 percent of patients have isolated diastolic heart failure, which is often associated with other illnesses such as hypertension, coronary artery disease, and diabetes. Heart failure seems to be an equal opportunity condition, in that it can happen to anyone. However, according to the National Heart, Lung, and Blood Institute, it is more prevalent in people age 65 or older and in African-Americans. Although men have a higher rate of heart failure than women, the condition affects more elderly women because they typically live longer.
Shortness of breath: Breathing becomes labored when fluid builds up in the lungs, a condition that physicians refer to as pulmonary edema or congestion. People with heart failure may experience breathlessness not only during activity or exercise but also while they rest or sleep. Sometimes they have trouble lying flat and need to prop up their heads and upper bodies on pillows. (Doctors call this condition orthopnea.) In addition, the shortness of breath may come on suddenly, waking people from a sound sleep. (Physicians have a name for this too: paroxysmal nocturnal dyspnea, or PND.) It is important to describe these symptoms every time you visit your heart failure specialist for a checkup because they mean that your treatment needs to be adjusted.
Coughing or wheezing: This symptom, too, is caused by fluid backing up in the lungs. People with heart failure often suffer from a persistent dry, hacking cough or a cough that produces white or pink blood-tinged mucus. Your doctor will determine whether your cough is from heart failure, another condition, or perhaps your medication. Fatigue: When the heart is unable to pump enough blood to feed the body’s tissues, the body compensates by redirecting blood from less critical organs, such as muscles in the limbs, and sending it to the heart and brain. This causes people with heart failure to feel very tired most of the time. Everyday tasks, including walking, climbing stairs, and taking a shower, become difficult. When simple tasks cause breathlessness, it’s called dyspnea.
Swelling: Swelling, also called edema, occurs because less blood travels to the kidneys, resulting in fluid and water retention. People with heart failure may experience swollen ankles, feet, legs, or abdomens. They often complain that their shoes feel too tight. Dizziness or confusion: Severe heart failure and low cardiac output can alter the levels of certain substances in the blood, such as sodium, which in turn may impair thinking. Family members, friends, or caregivers may be the first to notice someone’s poor memory or disorientation. In addition, heart failure may also increase the chance of blood clotting, so changes in mental status could also signal a stroke. Poor appetite: Like other body systems, the digestive system receives less blood when heart failure is present, which in turn causes problems with digestion. Lower cardiac output and fluid retention can lead to a tender or swollen abdomen. Heart failure patients often complain that they feel full or bloated or experience nausea or indigestion.
Yaz Lawyer
Januvia Class Action
Januvia Class Action News – 4/27/2012: If you were prescribed Januvia and have suffered negative side effects, please contact us today so that we can put you in touch with an attorney to advise you of your legal rights.
Januvia Class Action: To understand cancer, we must understand how the inner blueprint of normal cells tells them when they should multiply. We must know how that blueprint becomes deranged in the heart of the cancer cell. The roots of cancer lie in that blueprint. This copying of base sequences becomes important when a cell grows and divides. During the process, a mother cell prepares to endow each of its future daughters with exact replicas of the DNA helices that it carries. This mother-to-daughter transmission allows the genetic information initially present in the DNA of a fertilized egg to be transmitted faithfully through a succession of hundreds of rounds of cell division to all of the trillions of descendant cells that form the adult human body.
To understand the roots of cancer, let us leave our discussion of cells and genes and turn to a radically different way of studying and describing human beings and their maladies—the science of epidemiology. Epidemiologists study disease incidence in large groups of people. Cancer epidemiologists, in particular, study the frequencies of cancers in various human populations. Their work is almost always motivated by a central question: How do various kinds of behavior or environment influence the frequency of specific kinds of cancers? The very notion of cancer incidence as an interesting topic for scientific study is relatively new. Until the nineteenth century, cancer was relatively rare, an observation largely explained by the fact that cancer is a disease of older people. In many European countries at the beginning of the nineteenth century, expected life span was only about thirty-five years. Many people who might have contracted cancer late in life were struck down far earlier by infectious disease, malnutrition, or accident.
On the rare occasion when cancer did strike, most attributed it to a random accident or an act of God. But some evidence accumulating after the last decade of the eighteenth century suggested an alternative explanation—that the appearance of a cancer could be tied to specific experiences or lifestyles of the cancer patients. This new mind-set started with physicians who began to document particular kinds of tumors affecting very distinct subpopulations of humanity.
Cancer risk was also found to vary dramatically between countries. Liver cancer was eighteen times more frequent in certain parts of Africa than in Great Britain. Stomach cancer struck Japanese eleven times more frequently than Americans. Colon cancer was ten to twenty times more common in the United States than in certain regions of Africa. These dramatic differences were not due to differences in inherited susceptibility. When individuals migrated from one part of the world to another, their children soon assumed the cancer risks typical of their new locations.
Januvia Class Action News: More information about your search
Januvia Class Action: The notion that cancer was not a random, spontaneous degeneration of the body’s tissues, but instead was actively induced, radically changed the thinking of many cancer researchers. If external agents triggered die disease, perhaps they could be identified and their mechanisms of action studied. Perhaps the entire process from the initial encounter with a cancer-causing agent to the appearance of a cancer could be uncovered. So, toward the end of the nineteenth century, scientists throughout the world tried to recreate cancer in laboratory animals—mice, rats, and rabbits. For years, all such attempts failed. Around 1950, several geneticists assembled the body of accumulated information on chemicals, X-rays, and mutations and came up with a grand unifying theory, which in truth was little more than speculation. It went like this. X-rays and certain chemicals can induce cancer. X-rays and cancer can also induce mutations in genes. Therefore, these cancer-causing agents act through their ability to cause mutations in the genes of exposed animals. Stated differently, carcinogens (cancer-causing agents) are really mutagens (mutation-causing agents), and the two processes are inextricably linked.
A human cell, normal or malignant, was suspected to carry many tens of thousands of genes in its DNA. Among these might be a small set of genes which, when mutated by chemical carcinogens, would trigger runaway cell growth. For the moment, the task of finding these few mutant genes inside a cancer cell was far beyond the reach of available technology. Interest in cancer viruses had revived in the 1960s, in part through the recruitment of a new generation of young researchers who were eager to exploit techniques of DNA analysis to dissect these cancer agents. Thinking about the origins of cancer underwent a revolutionary change. For the first time, it became plausible that the roots of the disease lay deep within normal cells. Each cell seemed to carry within its normal genome the seed of its own destruction in a gene that it used to carry out its normal, everyday business.
Januvia Class Action News: Additional Information and Resources
Januvia Class Action: Plant foods present a double-edged sword, since they contain both cancer-causing and cancer-preventing compounds. Vegetables provide vitamins such as A, C, and E, which neutralize some important carcinogens, notably die oxidants and free radicals generated during normal cell metabolism. On the other hand, some plant components may actively contribute to cancer. Plants have evolved elaborate chemical defense systems to make themselves unpalatable to insect predators. Among these are compounds that are registered as potent mutagens in the Ames test. Ames himself has cited the case of a new strain of celery that was bred to require less synthetic insecticide during its cultivation; the increased insect resistance shown by this celery correlated with a tenfold increase in a potent mutagen that is found naturally in this vegetable.
Early detection of tumors will prove increasingly important. The discovery and removal of a tumor mass in its initial stages often results in a cure. But early detection presents two major difficulties. First, nests of cancer cells must be discovered while they are still very small. As we saw earlier, a tumor of one centimeter diameter constitutes less than 0.01 percent of the body’s mass. Few currently available biochemical assays are sensitive enough to detect such minute entities. Second, cancer cells, especially those in the early stages of tumor progression, are in almost all respects very much like normal cells. The task of finding distinctive markers that are specific to cancer cells is daunting. Almost all proteins that have been proclaimed “tumor-specific” have later been found to be produced also by normal tissues somewhere in the body.
Familial tumors also contribute to a substantial fraction of human cancer incidence. Some researchers estimate that as much as 10 percent of all human cancer derives from inherited genes. The ability to predict inborn susceptibility to cancer thus represents another highly useful dimension of early detection. The technology for detecting mutant genes in small tissue samples is improving rapidly. Soon, a mutant inherited gene predisposing an individual to one or another cancer will be readily detectable using only several chops of that person’s blood. Similar analyses will be available for prenatal diagnosis, to be used in families known to be afflicted with unusually high rates of certain cancers. These tests will identify those members of a family who are at high risk and those who are spared that risk. Family members who are found to be at risk will need to be monitored throughout their lives. In the case of especially life-threatening conditions, including familial polyposis and breast cancer, the patient may decide to have the target organ removed before a malignant tumor appears.
Our use of the term or terms Januvia Class Action is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Januvia Class Action News visit our site often.
Byetta Class Action
Byetta Class Action News – 4/27/2012: If you were prescribed Byetta and have suffered negative side effects, please contact us today so that we can put you in touch with an attorney to advise you of your legal rights.
Byetta Class Action: Tumor cells usually resort to a more expedient way of eliminating the second copy of a tumor suppressor gene. Their strategy depends on the fact that the two partners in a human chromosome pair (such as the two thirteenth chromosomes, each of which carries an Rb gene copy) often line up next to one another in parallel array, look each other over, compare their respective DNA sequences, and then swap genetic information. One frequent result is that a gene sequence present on one chromosome will now replace the corresponding sequence carried by its partner. Before this information transfer, two distinct versions of a gene may have resided on the two paired chromosomes; afterward, one of these versions is lost, being replaced by a duplicated version of the gene originally present on the other chromosome.
Precancerous tumor cells on their way to becoming actively malignant will often use this trick to eliminate both copies of a tumor suppressor gene that has been holding back their growth. They will first mutate to inactivity one copy of the gene and then eliminate its partner through this loss-of-heterozygosity homogenization. Importantly, the chromosomal swaps that generate this homogenization often involve large regions of the chromosome surrounding the tumor suppressor gene, not just the gene itself. Hundreds of genes residing to the left and the right of the tumor suppressor gene on a chromosome will also become homogenized. Of course, the homogenization of neighboring gene copies is irrelevant for the growth of the developing tumor cells. These neighboring genes are nothing more than innocent bystanders. It is realty only the tumor suppressor gene that the tumor cell is intent on eliminating through use of the homogenization trick.
Two things changed in modern times. We now live much longer than we used to. By the middle of the twentieth century, many of us began to live for seventy or eighty years, an age when this disease strikes frequently. A hundred years earlier, relatively few survived long enough to confront it. Our diet also changed from one heavy in grains and vegetables to fare that increasingly emphasized meat and large amounts of fat. The effects of diet are apparent from epidemiology: There are regions of Africa whose inhabitants follow a diet based almost exclusively on vegetables and grains. These people run a risk of colon cancer that is less than one-tenth of that seen in the West.
Byetta Class Action News: More information about your search
Byetta Class Action: Some humans make these detoxifying enzymes at high levels, while others produce them at much lower levels. These differences, which are heritable, offer us the opportunity to understand the roles of these enzymes in protecting cells against attack by various carcinogens. For example, do individuals with low levels of these protective enzymes contract cancer more often than those having high levels? In fact, some striking differences have been uncovered. Smokers who make low levels of the NAT enzyme (N-acetyl transferase) run as much as two and a half times the risk of bladder cancer compared to smokers having high levels of the NAT enzyme. Low levels of a second detoxifying enzyme, GSTMl (glutathione-S-transferase Ml), result in a threefold increase in the risk of lung cancer. These findings suggest that we may one day be able to calculate smokers’ risk of cancer based on their lifelong cigarette consumption and their levels of detoxifying enzymes.
Some mutagens succeed in penetrating this complex array of protective devices. Having escaped inactivation, these mutagens may proceed to react with and thereby damage the DNA molecules carried in the cell’s chromosomes. Every human cell sustains thousands of such mutagenic attacks every day. But in spite of this barrage, the cell’s DNA emerges at the end of the day relatively unscathed. This discrepancy demands explanation.
Close scrutiny of the machinery used by the cell to copy its DNA molecules reveals a similar discrepancy. The process by which cells replicate DNA in preparation for cell division is prone to error. Immediately after DNA polymerase—the enzyme responsible for DNA replication—has copied a stretch of DNA, as many as one in every thousand bases of the newly made DNA strand may be incorrect, having been mistakenly inserted by the polymerase. But as before, the actual rate at which mutations accumulate in the DNA is much lower. Somehow, the vast majority of these initial copying mistakes are not perpetuated in the DNA.
This dynamic has direct consequences for tumor formation: If the DNA repair process fails, large numbers of altered bases will accumulate in a cell’s DNA. This means that the rate at which mutations accumulate is influenced by at least three distinct processes: damage inflicted on the DNA by mutagens of foreign or internal origin, mistakes made during DNA copying, and defects in die DNA repair machinery responsible for erasing the damage created by mutagens or miscopying. Since mutation is the engine that drives tumor progression, all three of these processes are likely to be involved in one way or another in causing cancer.
Byetta Class Action News: Additional Information and Resources
Byetta Class Action: Knowing about mutant genes allows us to trace the roots of cancer back to discrete, identifiable changes in the central controlling molecule of the cell, its DNA. But in one sense, these genetic discoveries are sterile and uninformative. Genes are pure information, nothing more than mathematical abstractions. Studied in isolation, they tell us little about the real life of the cell. Moreover, the sequence of DNA bases that constitutes a gene usually reveals little about how this gene operates. So, even after we know that one or another gene is mutated during the development of a cancer, we still understand next to nothing about the mechanisms by which this mutant gene causes abnormal cell growth. Fortunately, molecular biology provides us with a useful train of logic that leads us toward an understanding of gene function. Genes instruct the cells around them to make specific proteins. It is the proteins that do the work of the genes. Proteins catalyze biochemical reactions or create elaborate physical structures. To understand how a gene works, we must know intimately how its protein functions.
In one sense, the roles played by the normal versions of oncoproteins are obvious: They help the normal cell regulate its growth. Unfortunately, this statement does not take us very far; it only restates the problem, and in a way that is not terribly useful. A more productive tack is suggested by the following question: Precisely how do normal cells know when to grow and when to hold back from growth? At any moment, the great majority of cells in our body are in a quiescent state. Only in tissues that renew themselves constantly, such as the colonic epithelium, the bone marrow (which generates new blood cells), and the skin, does one find large numbers of cells actively growing and dividing.
These dramatic differences in the proliferation rates of tissues bring us back to our question: Precisely how do any of these cells know when they should grow? The issue becomes even more complicated in the case of embryonic development, where cell proliferation results in the creation of new, complex tissues rather than the maintenance of an existing tissue architecture.
Our use of the term or terms Byetta Class Action is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Byetta Class Action News visit our site often.
Januvia Lawsuit
Januvia Lawsuit News – 4/27/2012: Did you take Januvia? Please contact us today if you took Januvia and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.
Januvia Lawsuit: Cancer wreaks havoc in almost every part of the human body. Tumors strike the brain and the gut, muscles and bones. Some grow slowly; others are more aggressive and expand quickly. Their presence in human tissues signals chaos and a breakdown of normal function. Cancer brings unwelcome change to a biological machine that is perfect, marvelously beautiful, and complex beyond measure. Wherever tumors appear, they take on the appearance of alien life forms, invaders that enter the body through stealth and begin their programs of destruction from within. But appearances deceive: The truth is much more subtle and endlessly interesting.
Tumors are not foreign invaders. They arise from the same material used by the body to construct its own tissues. Tumors use the same components—human cells-—to form the jumbled masses that disrupt biological order and function and, if left unchecked, to bring the whole complex, life- sustaining edifice that is the human body crashing down. How are human tissues put together from single cells? The description above might suggest the involvement of master builders who oversee crews of workers, directing them in the detailed construction of normal and malignant tissues. In reality, there are no overseers forcing throngs of cells to line up and assemble themselves into normal or cancerous tissues. Architectural complexity in living tissue comes from the bricks themselves, the individual cells. Control is exercised from the bottom up.
Normal and malignant cells know how to build. Each carries its own agenda that tells it when it should grow and divide and how it should aggregate with other cells to create organs and tissues. Our bodies are nothing more than highly complex societies of rather autonomous cells, each retaining many of the attributes of a fully independent organism. Right there, we confront great beauty and profound danger. The beauty lies in the coordinated behavior of so many cells to create the single, highly functional cooperative that is the human body. The danger lies in the absence of a single overseeing master builder, which seems to put the whole enterprise at great risk. Granting autonomy to trillions of worker cells invites chaos. When, as usually happens, these cells are well behaved and public-spirited, extraordinarily complex order ensues. But on occasion, a cell may choose to go its own way and invent its own novel version of a tissue or organ. It is then that we see the much-feared chaos that we call cancer.
Januvia Lawsuit News: More information about your search
Januvia Lawsuit: Most human tumors comprise a billion or more cells before we become aware of them. The cells within a tumor differ from their normal counterparts in many respects, exhibiting distinctive shapes, growth properties, and metabolism. The sudden appearance of such a horde of cells would seem to reflect some recent mass conversion, in which millions of normal cells enlisted overnight in the ranks of a tumor mass. Once again, appearances deceive. The creation of a tumor is an extraordinarily slow process, often extending over decades. The cells forming a tumor are all lineal descendants of a single progenitor, a distant ancestor that lived many years before the tumor mass became apparent. This founder, this renegade cell, decided to go off on its own, to begin its own growth, program within one of the body’s tissues. Thereafter, its proliferation was controlled by its own internal agenda rather than the needs of the community of cells around it.
So there were no millions of recruits, only a single one that spawned a vast horde of like-minded descendants. The billions of cells in a tumor are cast in the image of their renegade ancestor. They have no interest in the well-being of the tissue and organism around them. Like the founder cell, they have only one program in mind: more growth, more replicas of themselves, unlimited expansion. The chaos they create makes it clear how very dangerous it is to entrust each cell in the human body with its own measure of independence. Still, that is how we are put together, and how all complex, many-celled organisms have been designed for the past 600 million years. Learning this, we realize that the chaos of cancer is not a modern affliction but a risk run by all multicellular organisms, from ancient to modern. Indeed, given the trillions of cells in the human body, is it not a wonder that cancer does not erupt often during our long lives?
The notion that cancer was not a random, spontaneous degeneration of the body’s tissues, but instead was actively induced, radically changed the thinking of many cancer researchers. If external agents triggered die disease, perhaps they could be identified and their mechanisms of action studied. Perhaps the entire process from the initial encounter with a cancer-causing agent to the appearance of a cancer could be uncovered. So, toward the end of the nineteenth century, scientists throughout the world tried to recreate cancer in laboratory animals—mice, rats, and rabbits. For years, all such attempts failed.
The first successes came in Japan in the first decade of die new century. Katsusaburo Yamagiwa took instruction from the far earlier studies of European chimney sweeps. Percival Pott’s initial observations of high rates of scrotal cancer in London chimney sweeps had been followed several decades later by the work of others who found that chimney sweeps on the Continent had much lower rates of this tumor. The difference seemed to be related to personal hygiene practices. The British chimney sweeps, like many of their eighteenth-century countrymen, rarely took baths, while the chimney sweeps on the Continent bathed frequently. It seemed that creosote tars from the London flues stuck to the skin of die British sweeps and triggered cancer unless washed away quickly.
Our use of the term or terms Januvia Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Januvia Lawsuit visit our site often.
Byetta Lawsuit Update
Byetta Lawsuit News – 4/26/2012: Did you take Byetta? Please contact us today if you took Byetta and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.
Byetta Lawsuit: At any moment, the great majority of cells in our body are in a quiescent state. Only in tissues that renew themselves constantly, such as the colonic epithelium, the bone marrow (which generates new blood cells), and the skin, does one find large numbers of cells actively growing and dividing. The cancer cell is a renegade. Unlike their normal counterparts, cancer cells disregard the needs of the community of cells around them. Cancer cells are only interested in their own proliferative advantage. They are selfish and very unsociable. Most important, unlike normal cells, they have learned to grow without any prompting from the community of cells around them.
In principle, information regulating growth might be passed from one cell to another by electrical signals or small organic molecules. For various reasons, however, evolution has solved this problem in another way. In all complex, multicellular organisms, this information is conveyed by small, soluble protein molecules termed growth factors. A growth factor protein is released by one cell, moves through intercellular space, and ultimately impinges on its target—another cell. The target cell then responds by initiating a program of growth and division.
Several types of cancer cells seem to have shed their normal complement of TGF-B receptors. It is unclear how retinoblastoma cells, for example, lose these receptors, but this loss provides clear growth advantage to these cells. Normal retinal cells experience substantial levels of TGF-B in the back of the eye. Lacking appropriate receptors, the retinoblastoma tumor cells are oblivious to TGF-B and therefore ignore its orders to stop.
Byetta Lawsuit News: More information about your search
Byetta Lawsuit: Runaway oncogenes and defective tumor suppressor genes would seem to provide a full explanation of why cancer cells grow uncontrollably. Mutant versions of these two classes of genes conspire to make cells grow when, by all rights, they should be resting and inactive. This collaboration was illustrated graphically by the case of colon carcinoma, which often involves mutations of the ras oncogene and three tumor suppressor genes. Still, this view fails to address an important reality of cell biology: Tissues have two very different ways of limiting cell proliferation. The first strategy depends on depriving cells of growth factors or exposing them to signals that discourage growth; these conditions result in nongrowing, quiescent cells. This strategy, so essential to the maintenance of normal order within a tissue, is disrupted by changes in various proto-oncogenes and tumor suppressor genes.
Cells in many tissues throughout the body may be consigned to death for a variety of reasons. One condition that will provoke cell death is illustrated by a simple experiment. If cells are taken from one or another tissue and cultured in dishes, they will double a limited number of times before they stop growing, become sickly, and eventually die, steps that are termed cell senescence and crisis. Human cell populations, as an example, will often double once a day for fifty to sixty days before they stop growing. This barrier to unlimited proliferation is often termed “cell mortality.” Cell mortality appears to be an important anticancer defense mechanism. Normal tissues seem to endow their cells with a limited number of doublings in order to erect a barrier to tumor development. This barrier ensures that incipient tumor cell populations will double only a limited number of times before they exhaust their allotment of doublings and cease growth.
The cell mortality barrier must be breached by developing tumor cell populations. A population of premalignant cells that lacks this ability to divide endlessly will be unable to expand into a mass of substantial, life-threatening size. Indeed, when tumor cells are placed in culture, they show an ability to multiply indefinitely, an indication that these cells have become “immortalized.”
The frequent loss of cells by apoptosis during embryonic development seems counter to intuition, which portrays embryo development as a period of vibrant expansion. It would seem that a well-designed embryo should create only the cells that it requires for the formation of its component tissues, no more and no less. But in truth, embryonic development is profligate and inefficient. In many locations in the developing embryo, far more cells are produced through cell division than will ever be used in the final developed organ or tissue. Some of these cells create tissues that are evolutionary vestiges having no use in the modern organism. Others are the results of failed attempts during development at constructing proper tissue architecture. Apoptosis is used much like the sculptor’s chisel to remove unwanted material.
Our use of the term or terms Byetta Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Byetta Lawsuit visit our site often.
Mesothelioma Attorney News
Mesothelioma Attorney News – 3/5/2012: More information about your search
Mesothelioma Attorney: As MPM is generally seen as a disease with a rapid fatal outcome, quality of life is one of the most important issues for a patient. Although the quality of life might be reflected by the performance status, no data are available on the correlation between prognostic factors and quality of life, or on the role of quality of life as a prognostic factor. In this regard the clinical needs do not parallel the academic search for prognostic factors. All prognostic factors in mesothelioma studies, apart from one, focus on survival in an attempt to discriminate patient populations with a relatively good or relatively poor prognosis. Only one study focuses on recurrence-free survival, but no factors have been described that predict other clinical issues. Prognostic factors can be separated into host-related prognostic factors, tumor-related factors, and environment-related factors. The host-related factors typify the patient, the tumor-related factors characterize the disease, and the environment-related factors arc external factors not directly related to either the disease or the patient. The prognostic factors that have been described for mesothelioma studies according to this classification are categorized. As illustrated, the prognostic factors may be included in more than one group. For instance, performance status is influenced by both comorbidity and tumor load, and therefore might be considered as both a host-related and a tumor-related factor. A remarkably large number of different factors have been evaluated for their prognostic significance, with a large number of biological parameters appearing to have an impact on prognosis. We will focus on the prognostic factors and describe their value as predictors of survival.
Anatomical staging is a major prognostic factor in MPM. Almost all prognostic factor studies that include staging in their analysis reveal a significant impact on survival and show that this effect adds to the other prognostic factors. Twelve studies support this statement whilst only two cannot confirm it. Despite this, staging is not generally accepted as a good prognostic factor for several reasons. Firstly, several different staging systems are in use, which makes direct comparison of the papers focusing on this subject difficult, Indeed, the radical multimodality therapy series of Sugar baker, describes a highly significant impact of one staging system on survival, while two other staging systems do not seem to have a predictive value in the same patient population. Secondly, proper staging of MPM requires a surgical procedure, which is a major disadvantage. Thorough staging is currently only indicated in patients eligible for major surgical procedures, and most patients tend to be inoperable at presentation. This implies that surgical staging is not routinely performed in all patients, and data on tumor stage are not available for every patient. Thirdly, the tools used for non-surgical staging differ considerably even within the populations from single hospitals.
Mesothelioma Attorney
Tekturna Attorney News
Tekturna Attorney News – 2/28/2012:
Tekturna side effects are being investigated by law firms that focus on pharmaceutical and medical device litigation. If you were prescribed Tekturna and later suffered serious negative side effects please contact us today so that we can arrange a free legal consultation about potentially recovering money damages for you injuries.
Tekturna Attorney: But not every stroke is found in the right or left hemisphere of the brain. As with most situations, there are exceptions to every rule. Although less common than their “right-left” counterparts, some strokes occur in the brain stem or in the cerebellum. Strokes here may affect movement, balance, and basic body functions, such as swallowing and breathing. Of course, we usually don’t see every symptom in every per”son who suffers a stroke. Nor are every person’s symptoms the same. But when stroke strikes a specific area, there are enough similarities to make pinpointing the location a help in diagnosis and, ultimately, in the rehabilitation outcome.
But depending on the specific function, one side does domi”nate the other. The right hemisphere is more in control of our visual organi”zation, perception, and attention. It adds meaning and substance to what we see. The right brain also is responsible for nonverbal communi”cation, for the slang, inflection, style, and gestures that go along with our conversations with others. Furthermore, our right hemisphere also is involved in our ability to perceive space, to understand where we are, what we are looking at, what we are doing, and why various objects are placed where they are.
And because the right brain governs our abil”ity to recognize visual and spatial cues, it makes sense that we would have difficulty with tasks that require us to see the rela”tionship of one thing to another. Neglect can mean many things. It can mean a failure to focus on the outside world. Or a lack of attention. Or, in its extreme, an inability to recognize that one has even had a stroke. In 1981, Dr. M. Mesulam isolated the attention network in the brain. He found that the small reticular formation, found deep within the brain stem, is responsible for general arousal and wakefulness. The parietal lobes concern themselves with sensory cues, and the frontal lobes help coordinate our actual activities. The limbic system provides the necessary desire and motivation to interact with our environment.
Tekturna Attorney
Tekturna Attorney: But not every stroke is found in the right or left hemisphere of the brain. As with most situations, there are exceptions to every rule. Although less common than their “right-left” counterparts, some strokes occur in the brain stem or in the cerebellum. Strokes here may affect movement, balance, and basic body functions, such as swallowing and breathing. Of course, we usually don’t see every symptom in every per”son who suffers a stroke. Nor are every person’s symptoms the same. But when stroke strikes a specific area, there are enough similarities to make pinpointing the location a help in diagnosis and, ultimately, in the rehabilitation outcome.
But depending on the specific function, one side does domi”nate the other. The right hemisphere is more in control of our visual organi”zation, perception, and attention. It adds meaning and substance to what we see. The right brain also is responsible for nonverbal communi”cation, for the slang, inflection, style, and gestures that go along with our conversations with others. Furthermore, our right hemisphere also is involved in our ability to perceive space, to understand where we are, what we are looking at, what we are doing, and why various objects are placed where they are.
And because the right brain governs our abil”ity to recognize visual and spatial cues, it makes sense that we would have difficulty with tasks that require us to see the rela”tionship of one thing to another. Neglect can mean many things. It can mean a failure to focus on the outside world. Or a lack of attention. Or, in its extreme, an inability to recognize that one has even had a stroke. In 1981, Dr. M. Mesulam isolated the attention network in the brain. He found that the small reticular formation, found deep within the brain stem, is responsible for general arousal and wakefulness. The parietal lobes concern themselves with sensory cues, and the frontal lobes help coordinate our actual activities. The limbic system provides the necessary desire and motivation to interact with our environment.
Tekturna Attorney
Mesothelioma Lawyers News
Mesothelioma Lawyers News – 3/5/2012: More information about your search
Mesothelioma Lawyers: Exposure to asbestos is the link to the development of mesothelioma. People who end up with this disease usually have had some type of previous exposure to asbestos. How this works is not fully understood. It is thought that asbestos fibers are inhaled and first travel through the upper air passages, which include the throat, the trachea (windpipe), and the large bronchi (large breathing tubes of the lungs). These airways are lined with mucus, and therefore most of the fibers are cleared from these upper airways by sticking to this mucus and being coughed up or swallowed. When the fibers continue to travel and reach the small airways (the alveoli), the body’s immune system is able to surround, engulf, and remove the smaller fibers by a process known as phagocytosis.
Malignant mesothelioma is a rare form of cancer that is found m the lining of the chest and lung (the pleura), the abdomen (the peritoneum), or the saclike space around the heart (the pericardium). Although it is rare, mesothelioma is a very serious disease that is often at an advanced stage when the diagnosis is made. In the United States an estimated 2000 to 3000 new cases of mesothelioma are diagnosed each year. Approximately three fourths of these cases start in the chest cavity and are called pleural mesotheliomas. Another 10% to 20% begin in the abdomen and are called peritoneal mesotheliomas. Lastly, those that start in the lining around the heart are called pericardial mesotheliomas, but these are extremely rare.
In America, asbestosis compensation cases began in 1927 when a Massachusetts asbestos textile worker filed a claim. A group of Johns- Manville workers launched claims in 1929 and by the mid-1930s at least sixty-nine more state compensation suits were brought against the company. During the 1930s, claims were filed against other leading manufacturers, such as Raybestos-Manhattan. The latter compensated about twenty cases in the 1930s, with average payments between $2,000 and $3,000, sometimes less. But it was no more than a trickle of cases. The low numbers reflected the lack of state coverage and the fact that the American system was adversarial, involving the court system. Insurers rarely accepted liability without a legal fight. It also reflected the stringency of compensation legislation. Here, too, many claims were ‘statute- barred’, so that workers could not claim if they had left the industry more than a year or had worked in more than one state. This was an especially cruel limitation for insulators with their itinerant work practices.
Selikoffs activities in Canada ended abruptly when the Quebec industry was nationalized, but before then trade union agitation at Thetford had triggered a federal inquiry. Published in 1976, it found that dust control was very poor and the lead investigator, Judge René Beaudry, found it ‘shocking’ that in some plants workers were still handling asbestos fiber with their bare hands. He went on to comment on employers: ‘They have kept available information about the dangerous effects of asbestos dust away from the workers and the unions.’ A similar picture was drawn by an Asbestosis Working Group in Ottawa, which suggested that McDonald’s statistics on mesothelioma were underestimated. These reports concluded that the industry was more concerned with medicalizing the asbestos problem through the compensation system and epidemiology than by spending money on protecting workers from the dust. Revelations were also emerging of poor working conditions at the Canadian plants of Johns-Manville in Scarborough, T&N in Montreal, and Bendix Automotive in Windsor.
Mesothelioma Lawyers
Tekturna Lawsuit Information
Tekturna Lawsuit: Just behind the brain stem, and slightly above it, sits the cerebel”lum, a mass of tissue that coordinates our every movement. It helps us keep our balance, allowing us to hold a glass of water steady. The cerebellum also coordinates the movements of our speech muscles. Working with the cerebellum are the basal ganglia, located in the higher parts of the brain, helping to smooth the way we move. Obviously, a stroke in either of these two areas of the brain can affect our balance and our movements.
This locale of the brain is the gateway to the higher-functioning areas of the brain. Situated right above the brain stem, the dien”cephalon is home to two crucial vice presidents. The thalamus is a relay station that sorts out the messages traveling to the brain and decides which areas get what. It might send a message to several areas of the brain at once. When you step on a nail, for example, the pain will shoot through your brain stem to your thalamus and on to your memory storage bank. You might remember when you were a kid and had to get a tetanus shot because you stepped on a rusty nail.
Look in the mirror. Imagine a line going straight down the middle of your head, dividing it into two perfectly similar mirror images. Indeed, it’s as if there were a line dividing your brain into perfect halves. We call these exact replicas the right and left hemispheres of the brain. Despite the use of “right brain-left brain speak” by pop psychologists to help people find everything from their “in”ner selves” to great relationships, there are very real—and differ”ent—functions for each hemisphere.
Tekturna Lawsuit
Kentucky Girl With Cerbral Palsy Gets Service Dog
Kentucky Girl with Cerebral Palsy Gets Service Dog
A Kentucky girl who was born with cerebral palsy has been given a companion dog by a group of companies that would ordinarily cost tens of thousands of dollars and will likely help her perform everyday tasks better than before.
According to Louisville’s NBC affiliate WAVE-TV, 5-year-old Addison Childers was born with cerebral palsy that affects her ability to walk and causes her to have seizures.
However, a partnership between Milk-Bone and Kroger recently led to Addison receiving a service dog from a non-profit organization that provides companion pets to people with disabilities.
“Her big issue is her balance and coordination, and she’s not able to walk around like typical children are,” said Dustin Childers, Addison’s father, according to Louisville ABC affiliate WDRB. “This dog is going to be a walking assistant to her, give her the ability to get around the classroom, get around our house just on a lot better scale than any walker can give her.”
If not for the gift from the companies, getting the dog could potentially have been a sizable expense. WAVE reported that the service dog was valued at $20,000.
If you have a child who was born with cerebral palsy, you are probably looking for any methods possible to make your child’s life as easy as possible, regardless of how expensive it may be. If you think your child’s cerebral palsy was caused by medical error, call Sokolove Law today to learn more about pursuing a birth injury lawsuit. Monetary compensation in a birth injury lawsuit can be designated specifically towards medical costs for your child.
Cerbral Palsy